##4080001
Research	research	nn1
has	have	vhz
identified	identify	vvn
a	a	at1
wide	wide	jj
range	range	nn1
of	of	io
health	health	nn1
conditions	condition	nn2
related	relate	vvn_vvd
to	to	ii
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
in	in	ii
studies	study	nn2
conducted	conduct	vvd_vvn
primarily	primarily	rr
in	in	ii
developed	developed	jj
countries	country	nn2
and	and	cc
in	in	ii
populations	population	nn2
with	with	iw
severe	severe	jj
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
problems	problem	nn2
.	.	y
Little	little	da1_rr
is	be	vbz
known	know	vvn
about	about	ii
medical	medical	jj
conditions	condition	nn2
in	in	ii
those	those	dd2
with	with	iw
less	less	rgr_dar
severe	severe	jj
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
in	in	ii
developing	developing	jj_vvg
countries	country	nn2
.	.	y
We	we	ppis2
used	use	vvd
WHO	who	np1
AUDIT	audit	nn1
and	and	cc
ASSIST	assist	vv0
screeners	screener	nn2
to	to	to
identify	identify	vvi
hazardous	hazardous	jj
drinking	drinking	nn1
or	or	cc
drug	drug	nn1
use	use	nn1_vv0
in	in	ii
public	public	jj
health	health	nn1
clinics	clinic	nn2
in	in	ii
Cape	cape	np1
Town	town	np1
,	,	y
South	south	np1
Africa	africa	np1
,	,	y
and	and	cc
included	include	vvd_vvn
questions	question	nn2
about	about	ii
doctor-diagnosed	doctor-diagnosed	jj
medical	medical	jj
conditions	condition	nn2
.	.	y
Using	use	vvg
logistic	logistic	jj
regression	regression	nn1
we	we	ppis2
examined	examine	vvd
the	the	at
relationship	relationship	nn1
of	of	io
medical	medical	jj
conditions	condition	nn2
to	to	ii
hazardous	hazardous	jj
alcohol	alcohol	nn1
,	,	y
drug	drug	nn1
and	and	cc
tobacco	tobacco	nn1
use	use	nn1
.	.	y
Those	those	dd2
with	with	iw
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
had	have	vhd
higher	high	jjr
prevalence	prevalence	nn1
of	of	io
many	many	da2
health	health	nn1
conditions	condition	nn2
including	including	ii
tuberculosis	tuberculosis	nn1
,	,	y
Hepatitis	hepatitis	np1
B	b	zz1_np1@
,	,	y
migraine	migraine	vv0_nn1
,	,	y
chronic	chronic	jj
bronchitis	bronchitis	nn1
,	,	y
and	and	cc
fiver	fiver	nn1
cirrhosis	cirrhosis	nn1
.	.	y
Optimal	optimal	jj
treatment	treatment	nn1
for	for	if
some	some	dd
medical	medical	jj
conditions	condition	nn2
may	may	vm
include	include	vvi
treatment	treatment	nn1
of	of	io
underlying	underlying	jj_vvg
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
,	,	y
particularly	particularly	rr
use	use	nn1_vv0
of	of	io
drugs	drug	nn2
other	other	ii21
than	than	ii22
alcohol	alcohol	nn1
.	.	y
In	in	ii
these	these	dd2
populations	population	nn2
,	,	y
access	access	nn1_vv0@
to	to	ii
substance	substance	nn1
use	use	nn1_vv0
treatment	treatment	nn1
is	be	vbz
limited	limit	vvn_jj
and	and	cc
even	even	rr
brief	brief	jj
interventions	intervention	nn2
or	or	cc
advice	advice	nn1
may	may	vm
be	be	vbi
useful	useful	jj
.	.	y
Many	many	da2
individuals	individual	nn2
presenting	present	vvg
in	in	ii_rp@
primary	primary	jj_nn1
care	care	nn1
have	have	vh0
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
problems	problem	nn2
(	(	y
Magruder-Habib		np1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
Ray	ray	np1
,	,	y
Fireman	fireman	nn1
&;		null
Walsh	walsh	np1
,	,	y
2005	2005	mc
)	)	y
.	.	y
A	a	at1_zz1
growing	growing	jj
body	body	nn1
of	of	io
research	research	nn1
has	have	vhz
identified	identify	vvn
a	a	at1
large	large	jj
range	range	nn1
of	of	io
medical	medical	jj
conditions	condition	nn2
related	relate	vvn_vvd
to	to	ii
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
,	,	y
such	such	ii21
as	as	ii22
hypertension	hypertension	nn1
,	,	y
HIV	hiv	np1
,	,	y
hepatitis	hepatitis	nn1
B	b	zz1
and	and	cc
C	c	zz1_np1
,	,	y
liver	liver	nn1
dysfunction	dysfunction	nn1
,	,	y
chronic	chronic	jj
liver	liver	nn1
disease	disease	nn1
,	,	y
epilepsy	epilepsy	nn1
,	,	y
and	and	cc
psychiatric	psychiatric	jj
disorders	disorder	nn2
(	(	y
Chou	chou	np1
,	,	y
Grant	grant	np1
,	,	y
&;		null
Dawson	dawson	np1
,	,	y
1996	1996	mc
;	;	y
Edwards	edwards	np1
&;		null
Peters	peters	np
,	,	y
1996	1996	mc
;	;	y
Rodgers	rodgers	np1
,	,	y
2002	2002	mc
;	;	y
Sikkink	sikkink	np1
&;		null
Fleming	fleming	np1
,	,	y
1992	1992	mc
;	;	y
Stein	stein	np1
,	,	y
1999	1999	mc
)	)	y
.	.	y
Despite	despite	ii
this	this	dd1
body	body	nn1
of	of	io
research	research	nn1
on	on	ii
the	the	at
association	association	nn1
of	of	io
medical	medical	jj
problems	problem	nn2
to	to	ii
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
use	use	nn1
and	and	cc
dependence	dependence	nn1
,	,	y
many	many	da2
gaps	gap	nn2
remain	remain	vv0
in	in	ii_rp@
the	the	at
literature	literature	nn1
.	.	y
First	first	md
,	,	y
there	there	ex
is	be	vbz
very	very	rg
little	little	da1
research	research	nn1
on	on	ii
the	the	at
relationship	relationship	nn1
of	of	io
medical	medical	jj
problems	problem	nn2
to	to	ii
substance	substance	nn1
for	for	if
those	those	dd2
with	with	iw
less	less	rgr_dar
severe	severe	jj
substance	substance	nn1
use	use	nn1_vv0
problems	problem	nn2
.	.	y
This	this	dd1
is	be	vbz
true	true	jj
despite	despite	ii
an	a	at1
increasing	increasing	jj
international	international	jj
focus	focus	nn1
on	on	ii
hazardous	hazardous	jj
drinking	drinking	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
--		nn1
defined	define	vvn
by	by	ii
the	the	at
World	world	nn1
Health	health	nn1
Organization	organization	nn1
(	(	y
WHO	who	np1
)	)	y
as	as	ii_csa
a	a	at1
pattern	pattern	nn1
of	of	io
use	use	nn1
which	which	ddq
confers	confer	vvz
the	the	at
risk	risk	nn1
of	of	io
"	"	y
health	health	nn1
and	and	cc
other	other	jj
problems	problem	nn2
"	"	y
(	(	y
Henry-Edwards		np1
,	,	y
Humeniuk		np1_vv0_nn1
,	,	y
Ali	ali	np1
,	,	y
Poznyak		np1
,	,	y
&;		null
Monteiro	monteiro	np1
2003	2003	mc
)	)	y
.	.	y
The	the	at
World	world	nn1
Medical	medical	jj
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
global	global	jj
impact	impact	nn1
of	of	io
Alcohol	alcohol	nn1
on	on	ii
Health	health	nn1
and	and	cc
Society	society	nn1
"	"	y
in	in	ii
which	which	ddq
it	it	pph1
characterizes	characterize	vvz
the	the	at
effects	effect	nn2
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
and	and	cc
recommends	recommend	vvz
that	that	cst
all	all	db
physicians	physician	nn2
screen	screen	vv0@_nn1
for	for	if
hazardous	hazardous	jj
drinking	drinking	nn1
(	(	y
The	the	at
World	world	nn1
Medical	medical	jj
Association	association	nn1
,	,	y
2005	2005	mc
)	)	y
.	.	y
WHO	who	np1_pnqs@
also	also	rr
recommends	recommend	vvz
screening	screen	vvg_nn1
for	for	if
other	other	jj
substances	substance	nn2
(	(	y
Henry-Edwards		np1
et	et	ra21
al.	al	ra22
,	,	y
2003	2003	mc
)	)	y
.	.	y
Compared	compare	vvn
to	to	ii
individuals	individual	nn2
meeting	meet	vvg_nn1
dependence	dependence	nn1
criteria	criteria	nn2
,	,	y
hazardous	hazardous	jj
drinkers	drinker	nn2
and	and	cc
drug	drug	nn1
users	user	nn2
are	be	vbr
less	less	rgr
likely	likely	jj
to	to	to
be	be	vbi
identified	identify	vvn
in	in	ii
family	family	nn1
,	,	y
work	work	vv0_nn1
,	,	y
or	or	cc
legal	legal	jj
settings	setting	nn2
.	.	y
Screening	screening	nn1
provides	provide	vvz
an	a	at1
opportunity	opportunity	nn1
to	to	to
intervene	intervene	vvi
,	,	y
prevent	prevent	vv0
worsening	worsening	jj
of	of	io
problems	problem	nn2
,	,	y
and	and	cc
improve	improve	vv0
overall	overall	jj_nn1
health	health	nn1
(	(	y
Edmunds	edmunds	np1
et	et	ra21
al.	al	ra22
,	,	y
1997	1997	mc
;	;	y
Institute	institute	nn1
of	of	io
Medicine	medicine	nn1
,	,	y
1990	1990	mc
)	)	y
.	.	y
Other	other	jj
studies	study	nn2
in	in	ii
developed	developed	jj
countries	country	nn2
have	have	vh0
found	find	vvn
screening	screening	nn1_vvg
and	and	cc
intervention	intervention	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	to
be	be	vbi
cost-effective	cost-effective	jj
because	because	cs
it	it	pph1
reduces	reduce	vvz
medical	medical	jj
costs	cost	nn2
(	(	y
Fleming	fleming	np1
et	et	ra21
al.	al	ra22
,	,	y
2002	2002	mc
)	)	y
.	.	y
As	as	ii_csa
the	the	at
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
field	field	nn1
is	be	vbz
broadening	broaden	vvg
the	the	at
focus	focus	nn1
from	from	ii
tertiary	tertiary	jj
to	to	ii
secondary	secondary	jj_nn1
prevention	prevention	nn1
and	and	cc
on	on	ii
the	the	at
need	need	nn1
for	for	if
screening	screen	vvg_nn1
and	and	cc
intervention	intervention	nn1
in	in	ii_rp@
previously	previously	rr
underserved	underserved	jj
populations	population	nn2
with	with	iw
less	less	rgr_dar
severe	severe	jj
problems	problem	nn2
,	,	y
there	there	ex
is	be	vbz
almost	almost	rr
no	no	at
research	research	nn1
documenting	document	vvg
the	the	at
medical	medical	jj
problems	problem	nn2
associated	associate	vvn
with	with	iw
these	these	dd2
less	less	dar
severe	severe	jj
problems	problem	nn2
.	.	y
This	this	dd1
is	be	vbz
particularly	particularly	rr
true	true	jj
regarding	regarding	ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
developing	developing	jj_vvg
nations	nation	nn2
.	.	y
With	with	iw
a	a	at1
few	few	da2
exceptions	exception	nn2
(	(	y
Rodgers	rodgers	np1
,	,	y
2002	2002	mc
)	)	y
little	little	rr_jj
prior	prior	jj
research	research	nn1
,	,	y
particularly	particularly	rr
that	that	cst_dd1
on	on	ii
primary	primary	jj_nn1
health	health	nn1
care	care	nn1
populations	population	nn2
,	,	y
has	have	vhz
been	be	vbn
conducted	conduct	vvn
in	in	ii
developed	developed	jj
countries	country	nn2
(	(	y
Magruder-Habib		np1
et	et	ra21
al.	al	ra22
,	,	y
1991	1991	mc
;	;	y
Mertens	mertens	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
.	.	y
Little	little	da1_rr
is	be	vbz
known	know	vvn
about	about	ii
this	this	dd1
relationship	relationship	nn1
in	in	ii
countries	country	nn2
such	such	ii21
as	as	ii22
South	south	nd1
Africa	africa	np1
,	,	y
where	where	rrq_cs
,	,	y
for	for	rex21
example	example	rex22
,	,	y
HIV	hiv	np1
and	and	cc
TB	tb	nn1
are	be	vbr
prevalent	prevalent	jj
.	.	y
Developing	developing	jj_vvg
nations	nation	nn2
may	may	vm
have	have	vhi
different	different	jj
patterns	pattern	nn2
of	of	io
substance	substance	nn1
use	use	nn1
and	and	cc
of	of	io
health	health	nn1
risks	risk	nn2_vvz@
from	from	ii
those	those	dd2
evident	evident	jj
in	in	ii
the	the	at
developed	developed	jj
world	world	nn1
(	(	y
Rodgers	rodgers	np1
,	,	y
2002	2002	mc
)	)	y
.	.	y
Until	until	ii
recently	recently	rr
the	the	at
main	main	jj
body	body	nn1
of	of	io
epidemiological	epidemiological	jj
research	research	nn1
has	have	vhz
focused	focus	vvn
on	on	ii
alcohol	alcohol	nn1
,	,	y
rather	rather	ii21_cs21@
than	than	ii22_cs22@
other	other	jj
drugs	drug	nn2
.	.	y
Heavy	heavy	jj
drinking	drinking	nn1
is	be	vbz
associated	associate	vvn
with	with	iw
liver	liver	nn1
and	and	cc
pancreatic	pancreatic	jj
disease	disease	nn1
,	,	y
hypertension	hypertension	nn1
,	,	y
reproductive	reproductive	jj
system	system	nn1
disorders	disorder	nn2
,	,	y
injury/trauma	injury/trauma	nn1
,	,	y
stroke	stroke	vv0_nn1
,	,	y
and	and	cc
fetal	fetal	jj
alcohol	alcohol	nn1
syndrome	syndrome	nn1
(	(	y
Chou	chou	np1
et	et	ra21
al.	al	ra22
,	,	y
1996	1996	mc
;	;	y
Dufour	dufour	np1
&;		null
Fe	fe	np1
Caces	caces	np2
,	,	y
1993	1993	mc
;	;	y
Gmel		np1
&;		null
Rehm	rehm	np1
,	,	y
2003	2003	mc
;	;	y
Gutjahr	gutjahr	np1_vv0
,	,	y
Gmel		np1
,	,	y
&;		null
Rehm	rehm	np1_nn1
,	,	y
2001	2001	mc
;	;	y
Mertens	mertens	np1
,	,	y
Lu	lu	np1_nn1
,	,	y
Parthasarathy	parthasarathy	np1_nn1
,	,	y
Moore	moore	np1
,	,	y
&;		null
Weisner	weisner	np1_nn1
,	,	y
2003	2003	mc
;	;	y
Mertens	mertens	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
;	;	y
Raab	raab	np1
,	,	y
1992	1992	mc
;	;	y
Rodgers	rodgers	np1
,	,	y
2002	2002	mc
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
show	show	vv0
associations	association	nn2
between	between	ii
particular	particular	jj
medical	medical	jj
problems	problem	nn2
and	and	cc
specific	specific	jj
drugs	drug	nn2
.	.	y
Long-term	long-term	jj
chronic	chronic	jj
marijuana	marijuana	nn1
use	use	nn1
is	be	vbz
associated	associate	vvn
with	with	iw
cognitive	cognitive	jj
impairments	impairment	nn2
such	such	ii21
as	as	ii22
memory	memory	nn1
and	and	cc
attention	attention	nn1
problems	problem	nn2
(	(	y
Ashton	ashton	np1
,	,	y
2001	2001	mc
;	;	y
Hall	hall	np1@
&;		null
Solowij	solowij	np1
,	,	y
1998	1998	mc
)	)	y
,	,	y
bronchitis	bronchitis	nn1
(	(	y
Ashton	ashton	np1
,	,	y
2001	2001	mc
;	;	y
Hall	hall	np1@
&;		null
Solowij	solowij	np1
,	,	y
1998	1998	mc
)	)	y
,	,	y
and	and	cc
cardiovascular	cardiovascular	jj
effects	effect	nn2
(	(	y
Ashton	ashton	np1
,	,	y
2001	2001	mc
)	)	y
.	.	y
There	there	ex
is	be	vbz
evidence	evidence	nn1
of	of	io
cardiovascular	cardiovascular	jj
complications	complication	nn2
among	among	ii
cocaine	cocaine	nn1
users	user	nn2
,	,	y
(	(	y
Lange	lange	np1
&;		null
Hillis	hillis	np1
,	,	y
2001	2001	mc
;	;	y
Rubin	rubin	np1
&;		null
Neugarten	neugarten	np1
,	,	y
1992	1992	mc
;	;	y
Stein	stein	np1
,	,	y
1999	1999	mc
)	)	y
as	as	ii31
well	well	ii32
as	as	ii33
neurological	neurological	jj
and	and	cc
psychiatric	psychiatric	jj
disorders	disorder	nn2
(	(	y
Grant	grant	np1
&;		null
Dawson	dawson	np1
,	,	y
1999	1999	mc
;	;	y
Rubin	rubin	np1
&;		null
Neugarten	neugarten	np1
,	,	y
1992	1992	mc
;	;	y
Stein	stein	np1
,	,	y
1999	1999	mc
)	)	y
.	.	y
We	we	ppis2
conducted	conduct	vvd
a	a	at1
study	study	nn1
in	in	ii
representative	representative	jj_nn1
public	public	jj_nn1
primary	primary	jj_nn1
health	health	nn1
care	care	nn1
clinics	clinic	nn2
in	in	ii
Cape	cape	np1
Town	town	np1
,	,	y
South	south	np1
Africa	africa	np1
to	to	to
examine	examine	vvi
the	the	at
association	association	nn1
of	of	io
self-reported	self-reported	jj_nn1
health	health	nn1
conditions	condition	nn2
to	to	ii
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
drug	drug	nn1
and	and	cc
tobacco	tobacco	nn1
use	use	nn1
.	.	y
If	if	cs
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
drug	drug	nn1
,	,	y
and	and	cc
tobacco	tobacco	nn1
users	user	nn2
have	have	vh0
a	a	at1
higher	high	jjr
risk	risk	nn1
of	of	io
medical	medical	jj
conditions	condition	nn2
(	(	y
particularly	particularly	rr
prevalent	prevalent	jj
conditions	condition	nn2
such	such	ii21
as	as	ii22
TB	tb	nn1
and	and	cc
hypertension	hypertension	nn1
)	)	y
,	,	y
as	as	csa
has	have	vhz
been	be	vbn
found	find	vvn
in	in	ii
a	a	at1
U.S.	us	np1
primary	primary	jj_nn1
care	care	nn1
population	population	nn1
(	(	y
Mertens	mertens	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
,	,	y
this	this	dd1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
countries	country	nn2
.	.	y
METHODS	method	nn2
SAMPLE	sample	vv0@
The	the	at
study	study	nn1
employed	employ	vvd_vvn
a	a	at1
multi-stage	multi-stage	nn1_jj
clustered	cluster	vvd_jj@
,	,	y
stratified	stratified	jj_vvn
sampling	sampling	nn1
design	design	nn1
in	in	ii
which	which	ddq
we	we	ppis2
first	first	md
sampled	sample	vvd_vvn
clinics	clinic	nn2
,	,	y
and	and	cc
then	then	rt_jj%
patients	patient	nn2
within	within	ii
clinics	clinic	nn2
.	.	y
We	we	ppis2
sampled	sample	vvd
14	14	mc
clinics	clinic	nn2
from	from	ii
the	the	at
49	49	mc
public	public	jj
health	health	nn1
clinics	clinic	nn2
providing	provide	vvg
primary	primary	jj_nn1
care	care	nn1
in	in	ii
Cape	cape	np1
Town	town	np1
.	.	y
In	in	ii
South	south	np1
Africa	africa	np1
,	,	y
the	the	at
racial	racial	jj
categories	category	nn2
defined	define	vvn_vvd
under	under	ii
apartheid	apartheid	nn1
-	-	-
black	black	jj
,	,	y
colored	color	vvd_vvn@_jj@
(	(	y
mixed	mixed	jj@_vvn
ancestry	ancestry	nn1
)	)	y
,	,	y
Indian	indian	jj
and	and	cc
white	white	jj
--		nn1
remain	remain	vv0
associated	associate	vvn_jj
with	with	iw
health	health	nn1
disparities	disparity	nn2
(	(	y
McIntyre	mcintyre	np1
,	,	y
Muirhead	muirhead	np1
,	,	y
&;		null
Gilson	gilson	np1
,	,	y
2002	2002	mc
)	)	y
and	and	cc
have	have	vh0
a	a	at1
long	long	jj
association	association	nn1
with	with	iw
access	access	nn1
both	both	rr
to	to	ii
alcohol	alcohol	nn1
and	and	cc
to	to	ii
treatment	treatment	nn1
(	(	y
Mager	mager	np1_vv0_nn1
,	,	y
2004	2004	mc
)	)	y
,	,	y
particularly	particularly	rr
in	in	ii
the	the	at
Western	western	np1
Cape	cape	np1
Province	province	nn1
(	(	y
McKinstry	mckinstry	np1
,	,	y
2005	2005	mc
)	)	y
.	.	y
Consistent	consistent	jj
with	with	iw
other	other	jj
South	south	np1
African	african	jj
research	research	nn1
,	,	y
we	we	ppis2
stratified	stratify	vvn
the	the	at
clinics	clinic	nn2
by	by	ii
predominant	predominant	jj
race	race	nn1
served	serve	vvn
by	by	ii
the	the	at
clinic	clinic	nn1
(	(	y
80%	80%	nnu
or	or	cc
more	more	dar
of	of	io
patients	patient	nn2
black	black	jj_vv0%_nn1@
,	,	y
80%	80%	nnu
or	or	cc
more	more	rrr_rgr
colored	color	vvd_jj@_vvn@
,	,	y
or	or	cc
serving	serve	vvg
a	a	at1
diverse	diverse	jj
population	population	nn1
)	)	y
because	because	ii21
of	of	ii22
the	the	at
continuing	continuing	jj
association	association	nn1
of	of	io
race	race	nn1
with	with	iw
health	health	nn1
disparities	disparity	nn2
(	(	y
Mager	mager	np1_vv0_nn1
,	,	y
2004	2004	mc
;	;	y
McIntyre	mcintyre	np1
et	et	ra21
al.	al	ra22
,	,	y
2002	2002	mc
;	;	y
McKinstry	mckinstry	np1
,	,	y
2005	2005	mc
)	)	y
(	(	y
for	for	if
additional	additional	jj
details	detail	nn2
about	about	ii
the	the	at
sampling	sampling	nn1
and	and	cc
procedures	procedure	nn2
,	,	y
see	see	vv0
Ward	ward	np1
,	,	y
in	in	ii
press	press	nn1
.	.	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
sampling	sample	vvg
equally	equally	rr
all	all	db
days	day	nnt2
of	of	io
clinic	clinic	nn1
operations	operation	nn2
across	across	ii
clinics	clinic	nn2
.	.	y
We	we	ppis2
recruited	recruit	vvd
2,618	2,618	mc
patients	patient	nn2
for	for	if
the	the	at
study	study	nn1
sample	sample	nn1
.	.	y
The	the	at
study	study	nn1
was	be	vbdz
approved	approve	vvn
by	by	ii
the	the	at
institutional	institutional	jj
review	review	nn1
boards	board	nn2
of	of	io
the	the	at
University	university	nn1
of	of	io
Cape	cape	np1
Town	town	np1
,	,	y
the	the	at
University	university	nn1
of	of	io
California	california	np1
,	,	y
San	san	np1
Francisco	francisco	np1
and	and	cc
the	the	at
Kaiser	kaiser	nnb
Foundation	foundation	np1
Research	research	nn1
Institute	institute	nn1
.	.	y
On	on	ii
data	data	nn
collection	collection	nn1
days	day	nnt2
,	,	y
we	we	ppis2
constructed	construct	vvd@
a	a	at1
log	log	nn1
of	of	io
all	all	db
patients	patient	nn2
who	who	pnqs
registered	register	vvd
,	,	y
along	along	ii21
with	with	ii22
their	their	appge
age	age	nn1
,	,	y
race	race	nn1_vv0@
,	,	y
and	and	cc
gender	gender	nn1
.	.	y
Using	use	vvg
the	the	at
log	log	nn1
,	,	y
we	we	ppis2
selected	select	vvd@
patients	patient	nn2
using	use	vvg
a	a	at1
sampling	sampling	nn1
fraction	fraction	nn1
to	to	to
obtain	obtain	vvi
ten	ten	mc
interviews	interview	nn2
per	per	ii
day	day	nnt1
.	.	y
We	we	ppis2
sampled	sample	vvd
every	every	at1
patient	patient	nn1_jj
aged	aged	ii@_jj_vvn
18-24	18-24	mcmc
since	since	cs
they	they	pphs2
come	come	vv0
to	to	ii
the	the	at
clinic	clinic	nn1
less	less	rgr_rrr
frequently	frequently	rr
and	and	cc
are	be	vbr
also	also	rr
particularly	particularly	rr
at	at	ii
risk	risk	nn1
for	for	if
substance	substance	nn1
use	use	nn1
(	(	y
Ward	ward	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
.	.	y
The	the	at
patient	patient	jj_nn1
log	log	nn1
data	data	nn
was	be	vbdz
also	also	rr
used	use	vvn
to	to	to
construct	construct	vvi
weights	weight	nn2
to	to	to
estimate	estimate	vvi
population-level	population-level	jj
statistics	statistics	nn
.	.	y
MEASURES	measure	nn2
We	we	ppis2
developed	develop	vvd
the	the	at
questionnaire	questionnaire	nn1
in	in	ii
English	english	nn1_jj
,	,	y
then	then	rt
translated	translate	vvd_vvn
it	it	pph1
into	into	ii
Afrikaans	afrikaans	nn1_jj
and	and	cc
isiXhosa	isixhosa	nn1
and	and	cc
checked	check	vvd
the	the	at
quality	quality	nn1
of	of	io
the	the	at
translation	translation	nn1
by	by	ii
back-translation	back-translation	nn1_jj
.	.	y
The	the	at
questionnaire	questionnaire	nn1
was	be	vbdz
developed	develop	vvn
during	during	ii
a	a	at1
pilot	pilot	nn1
study	study	nn1
(	(	y
Ward	ward	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
in	in	ii
which	which	ddq
items	item	nn2
were	be	vbdr
modified	modify	vvn
for	for	if
cultural	cultural	jj
relevance	relevance	nn1
(	(	y
see	see	vv0
below	below	rl
)	)	y
.	.	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
marital	marital	jj
status	status	nn1
,	,	y
education	education	nn1
,	,	y
employment	employment	nn1
,	,	y
and	and	cc
religion	religion	nn1
.	.	y
For	for	if
socioeconomic	socioeconomic	jj
status	status	nn1
,	,	y
we	we	ppis2
used	use	vvd
items	item	nn2
from	from	ii
the	the	at
South	south	np1
African	african	jj
census	census	nn1
measuring	measure	vvg
relative	relative	jj_nn1
deprivation	deprivation	nn1
in	in	ii
urban	urban	jj
areas	area	nn2
(	(	y
McIntyre	mcintyre	np1
et	et	ra21
al.	al	ra22
,	,	y
2002	2002	mc
)	)	y
;	;	y
access	access	nn1_vv0@
to	to	ii
piped	piped	jj@
water	water	nn1
;	;	y
access	access	nn1_vv0@
to	to	ii
electricity	electricity	nn1
at	at	ii
home	home	nn1
;	;	y
living	live	vvg_nn1
in	in	ii
formal	formal	jj
housing	housing	nn1
rather	rather	ii21
than	than	ii22
a	a	at1
shack	shack	nn1
or	or	cc
traditional	traditional	jj
dwelling	dwelling	nn1
;	;	y
and	and	cc
employment	employment	nn1
status	status	nn1
of	of	io
the	the	at
head	head	nn1
of	of	io
household	household	nn1
.	.	y
SUBSTANCE	substance	nn1
USE	use	vv0_nn1
We	we	ppis2
used	use	vvd
the	the	at
AUDIT	audit	nn1
(	(	y
Alcohol	alcohol	nn1
Use	use	nn1_vv0
Disorders	disorder	nn2
Test	test	vv0_nn1
)	)	y
(	(	y
Babor	babor	np1_nn1
,	,	y
Higgins-Biddle		np1
,	,	y
Saunders	saunders	np1
,	,	y
&;		null
Monteiro	monteiro	np1
,	,	y
2001	2001	mc
)	)	y
to	to	to
assess	assess	vvi
hazardous	hazardous	jj
alcohol	alcohol	nn1
use	use	nn1
and	and	cc
the	the	at
ASSIST	assist	vv0
(	(	y
Alcohol	alcohol	nn1
,	,	y
Smoking	smoke	vvg_jj_nn1
and	and	cc
Substance	substance	nn1
Involvement	involvement	nn1
Screening	screening	nn1_vvg
Test	test	nn1
)	)	y
(	(	y
WHO	who	np1_pnqs@
ASSIST	assist	vv0
Humeniuk		np1_nn1
,	,	y
Ali	ali	np1
et	et	ra21
al.	al	ra22
,	,	y
2008	2008	mc
;	;	y
Newcombe	newcombe	np1
,	,	y
Humeniuk		np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
;	;	y
Working	working	jj
Group	group	nn1
,	,	y
2002	2002	mc
)	)	y
to	to	to
assess	assess	vvi
moderate	moderate	jj
to	to	ii
high	high	jj
risk	risk	nn1
use	use	nn1
of	of	io
tobacco	tobacco	nn1
and	and	cc
other	other	jj
drugs	drug	nn2
.	.	y
Both	both	db2
instruments	instrument	nn2
were	be	vbdr
designed	design	vvn
for	for	if
primary	primary	jj_nn1
care	care	nn1
clinic	clinic	nn1
use	use	nn1
and	and	cc
were	be	vbdr
developed	develop	vvn
and	and	cc
validated	validate	vvn
across	across	ii
many	many	da2
developed	developed	jj
and	and	cc
developing	developing	jj_vvg
countries	country	nn2
(	(	y
Babor	babor	np1
et	et	ra21
al.	al	ra22
,	,	y
2001	2001	mc
;	;	y
Humeniuk		np1
et	et	ra21
al.	al	ra22
,	,	y
2008	2008	mc
;	;	y
Newcombe	newcombe	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
;	;	y
WHO	who	np1_pnqs@
ASSIST	assist	vv0
Working	working	jj
Group	group	nn1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
potentially	potentially	rr
harmful	harmful	jj
alcohol	alcohol	nn1
,	,	y
tobacco	tobacco	nn1
,	,	y
and	and	cc
other	other	jj
drug	drug	nn1
use	use	nn1_vv0
behaviors	behavior	nn2
(	(	y
i.e.	ie	rex
,	,	y
"	"	y
hazardous	hazardous	jj
"	"	y
or	or	cc
"	"	y
moderate	moderate	jj
risk	risk	nn1
"	"	y
use	use	nn1
)	)	y
who	who	pnqs
can	can	vm
benefit	benefit	vvi
from	from	ii
brief	brief	jj
interventions	intervention	nn2
(	(	y
Babor	babor	np1
et	et	ra21
al.	al	ra22
,	,	y
2001	2001	mc
;	;	y
Babor	babor	np1
&;		null
Higgins-Biddle		np1
,	,	y
2001	2001	mc
;	;	y
Reid	reid	np1
,	,	y
Fiellin		np1
,	,	y
O'Conner	o'conner	np1
,	,	y
1999	1999	mc
)	)	y
;	;	y
hereafter	hereafter	rt
we	we	ppis2
refer	refer	vv0
to	to	ii
this	this	dd1
threshold	threshold	nn1
as	as	csa_rg@
"	"	y
hazardous	hazardous	jj
use	use	nn1
.	.	y
"	"	y
The	the	at
AUDIT	audit	nn1
is	be	vbz
a	a	at1
10-item	10-item	jj_nn1
instrument	instrument	nn1
,	,	y
with	with	iw
possible	possible	jj
scores	score	nn2
ranging	range	vvg
from	from	ii
0	0	mc
to	to	ii
40	40	mc
,	,	y
which	which	ddq
measures	measure	vvz@
quantity	quantity	nn1
and	and	cc
frequency	frequency	nn1
of	of	io
drinking	drinking	nn1_vvg
,	,	y
frequency	frequency	nn1
of	of	io
binge	binge	nn1
drinking	drinking	nn1_vvg
,	,	y
harmful	harmful	jj
use	use	nn1
(	(	y
i.e.	ie	rex
,	,	y
blackouts	blackout	nn2
or	or	cc
injuries	injury	nn2
after	after	ii_cs
drinking	drinking	nn1_vvg
,	,	y
others	others	nn2
'	'	ge
expressing	express	vvg
concern	concern	nn1
about	about	ii
drinking	drinking	nn1_vvg
,	,	y
and	and	cc
feeling	feel	vvg_nn1
remorse	remorse	nn1
)	)	y
and	and	cc
dependence	dependence	nn1
symptoms	symptom	nn2
(	(	y
i.e.	ie	rex
,	,	y
loss	loss	nn1
of	of	io
control	control	nn1
over	over	ii
drinking	drinking	nn1_vvg
,	,	y
morning	morning	nnt1
drinking	drinking	nn1_vvg
,	,	y
and	and	cc
,	,	y
"	"	y
failing	fail	vvg
to	to	to
do	do	vdi
what	what	ddq
was	be	vbdz
normally	normally	rr
expected	expect	vvn_vvd
because	because	ii21
of	of	ii22
drinking	drink	vvg_nn1
"	"	y
)	)	y
.	.	y
Scores	score	nn2
of	of	io
8	8	mc
or	or	cc
more	more	rrr_rgr
define	define	vv0
"	"	y
hazardous	hazardous	jj
drinking	drinking	nn1
"	"	y
or	or	cc
individuals	individual	nn2
in	in	ii31
need	need	ii32
of	of	ii33
at	at	rr21
least	least	rr22
a	a	at1
brief	brief	jj
intervention	intervention	nn1
(	(	y
Babor	babor	np1
&;		null
Higgins-Biddle		np1
,	,	y
2001	2001	mc
;	;	y
Babor	babor	np1
et	et	ra21
al.	al	ra22
,	,	y
2001	2001	mc
;	;	y
National	national	jj
Institute	institute	nn1
on	on	ii
Alcohol	alcohol	nn1
Abuse	abuse	nn1
and	and	cc
Alcoholism	alcoholism	nn1
,	,	y
2005	2005	mc
)	)	y
.	.	y
A	a	at1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
drank	drink	vvd
two	two	mc
to	to	ii
three	three	mc
times	time	nnt2
a	a	at1
week	week	nnt1
(	(	y
3	3	mc
points	point	nn2_vvz
)	)	y
,	,	y
drank	drink	vvd
more	more	dar
than	than	csn
two	two	mc
drinks	drink	nn2
on	on	ii
a	a	at1
typical	typical	jj
day	day	nnt1
(	(	y
1	1	mc1
point	point	nn1
)	)	y
,	,	y
had	have	vhd
six	six	mc
or	or	cc
more	more	dar
drinks	drink	nn2
on	on	ii
one	one	mc1
occasion	occasion	nn1
at	at	rr21
least	least	rr22
monthly	monthly	jj
(	(	y
2	2	mc
points	point	nn2_vvz
)	)	y
,	,	y
"	"	y
had	have	vhd
a	a	at1
relative	relative	jj_nn1
or	or	cc
friend	friend	nn1
,	,	y
a	a	at1
doctor	doctor	nn1
or	or	cc
other	other	jj
health	health	nn1
worker	worker	nn1
"	"	y
say	say	vv0
that	that	cst
they	they	pphs2
have	have	vh0
,	,	y
"	"	y
been	be	vbn
concerned	concerned	jj
about	about	ii
your	your	appge
drinking	drinking	nn1
or	or	cc
suggested	suggest	vvd
you	you	ppy
cut	cut	vv0
down	down	rp
"	"	y
in	in	ii
the	the	at
past	past	jj_nn1
year	year	nnt1
(	(	y
4	4	mc
points	point	nn2_vvz
)	)	y
,	,	y
for	for	if
a	a	at1
total	total	jj
score	score	nn1
of	of	io
10	10	mc
.	.	y
The	the	at
ASSIST	assist	vv0
asks	ask	vvz
six	six	mc
questions	question	nn2
for	for	if
each	each	dd1
of	of	io
eight	eight	mc
types	type	nn2
of	of	io
drugs	drug	nn2
(	(	y
i.e.	ie	rex
,	,	y
cannabis	cannabis	nn1
,	,	y
cocaine	cocaine	nn1
,	,	y
amphetamines	amphetamine	nn2_vvz
,	,	y
inhalants	inhalant	nn2
,	,	y
sedatives	sedative	nn2
,	,	y
hallucinogens	hallucinogen	nn2
,	,	y
opiates	opiate	nn2_vvz
,	,	y
and	and	cc
"	"	y
other	other	jj_nn1@
"	"	y
)	)	y
and	and	cc
tobacco	tobacco	nn1
.	.	y
These	these	dd2
questions	question	nn2
are	be	vbr
:	:	y
frequency	frequency	nn1
of	of	io
use	use	nn1
,	,	y
having	have	vhg
a	a	at1
"	"	y
strong	strong	jj
desire	desire	nn1
or	or	cc
urge	urge	vv0_nn1
"	"	y
to	to	to
use	use	vvi
,	,	y
having	have	vhg
had	have	vhn
legal	legal	jj
,	,	y
financial	financial	jj
,	,	y
social	social	jj
,	,	y
or	or	cc
health	health	nn1
consequences	consequence	nn2
of	of	io
use	use	nn1
,	,	y
failing	fail	vvg
to	to	to
do	do	vdi
what	what	ddq
was	be	vbdz
normally	normally	rr
expected	expect	vvn_vvd
because	because	ii21
of	of	ii22
use	use	nn1
,	,	y
having	have	vhg
someone	someone	pn1
express	express	jj@
concern	concern	nn1
about	about	ii
use	use	nn1
,	,	y
and	and	cc
having	have	vhg
failed	fail	vvn
to	to	to
cut	cut	vvi
down	down	rp
or	or	cc
stop	stop	vvi
using	use	vvg
.	.	y
Possible	possible	jj
ASSIST	assist	vv0
scores	score	nn2
for	for	if
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
25	25	mc
for	for	if
tobacco	tobacco	nn1
.	.	y
We	we	ppis2
adapted	adapt	vvd
the	the	at
ASSIST	assist	vv0
to	to	ii
local	local	jj
conditions	condition	nn2
in	in	ii
two	two	mc
ways	way	nn2
(	(	y
Ward	ward	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
;	;	y
Ward	ward	np1
et	et	ra21
al.	al	ra22
,	,	y
in	in	ii
press	press	nn1
)	)	y
.	.	y
First	first	md
,	,	y
methaqualone	methaqualone	nn1_vv0
was	be	vbdz
added	add	vvn
to	to	ii
the	the	at
list	list	nn1
of	of	io
drugs	drug	nn2
,	,	y
as	as	csa
it	it	pph1
is	be	vbz
one	one	mc1
of	of	io
the	the	at
most	most	rgt
frequently	frequently	rr
used	used	jj_vvn
drugs	drug	nn2
in	in	ii
South	south	np1
Africa	africa	np1
.	.	y
Second	second	md
,	,	y
local	local	jj
drug	drug	nn1
names	name	nn2
were	be	vbdr
used	use	vvn_jj
(	(	y
such	such	ii21
as	as	ii22
"	"	y
dagga	dagga	nn1
"	"	y
for	for	if
cannabis	cannabis	nn1
,	,	y
and	and	cc
"	"	y
Mandrax	mandrax	vv0_nn1
"	"	y
for	for	if
methaqualone	methaqualone	nn1
)	)	y
.	.	y
For	for	if
tobacco	tobacco	nn1
,	,	y
we	we	ppis2
included	include	vvd
use	use	nn1
of	of	io
a	a	at1
pipe	pipe	nn1
and	and	cc
snuff	snuff	nn1_vv0
,	,	y
both	both	db2
of	of	io
which	which	ddq
are	be	vbr
commonly	commonly	rr
used	use	vvn_vvd
in	in	ii
South	south	np1
Africa	africa	np1
.	.	y
For	for	if
the	the	at
WHO	who	np1
ASSIST	assist	vv0
specific	specific	jj
scores	score	nn2
for	for	if
each	each	dd1
substance	substance	nn1
reported	report	vvn
in	in	ii
the	the	at
prior	prior	jj_rr
three	three	mc
months	month	nnt2
are	be	vbr
calculated	calculate	vvn
.	.	y
A	a	zz1_at1
WHO	who	np1
ASSIST	assist	vv0
score	score	nn1
of	of	io
4	4	mc
or	or	cc
higher	high	jjr_rrr@
on	on	ii
tobacco	tobacco	nn1
or	or	cc
any	any	dd
drug	drug	nn1
other	other	ii21
than	than	ii22
alcohol	alcohol	nn1
is	be	vbz
an	a	at1
indicator	indicator	nn1
that	that	cst
the	the	at
patient	patient	nn1
has	have	vhz
moderate	moderate	jj
(	(	y
i.e.	ie	rex
,	,	y
patient	patient	nn1
is	be	vbz
a	a	at1
problematic	problematic	jj
drug	drug	nn1
user	user	nn1
)	)	y
to	to	ii
high	high	jj
(	(	y
i.e.	ie	rex
,	,	y
patient	patient	nn1
is	be	vbz
possibly	possibly	rr
dependent	dependent	jj
drug	drug	nn1
user	user	nn1
)	)	y
risk	risk	nn1_vv0
and	and	cc
needs	need	vvz
an	a	at1
intervention	intervention	nn1
(	(	y
WHO	who	np1_pnqs@
ASSIST	assist	vv0
Working	working	jj
Group	group	nn1
,	,	y
2002	2002	mc
)	)	y
(	(	y
Humeniuk		np1
et	et	ra21
al.	al	ra22
,	,	y
2008	2008	mc
;	;	y
Newcombe	newcombe	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
;	;	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
to	to	ii
this	this	dd1
threshold	threshold	nn1
of	of	io
moderate	moderate	jj
to	to	ii
high	high	jj
risk	risk	nn1
as	as	csa_rg@
"	"	y
hazardous	hazardous	jj
drug	drug	nn1
and	and	cc
tobacco	tobacco	nn1
users	user	nn2
.	.	y
"	"	y
A	a	at1
sample	sample	nn1
profile	profile	nn1
of	of	io
someone	someone	pn1
with	with	iw
hazardous	hazardous	jj
cannabis	cannabis	nn1
use	use	nn1
would	would	vm
be	be	vbi
someone	someone	pn1
who	who	pnqs
used	use	vvd
cannabis	cannabis	nn1
weekly	weekly	nn1@_jj
(	(	y
3	3	mc
points	point	nn2_vvz
)	)	y
and	and	cc
who	who	pnqs
,	,	y
in	in	ii
the	the	at
past	past	jj
3	3	mc
months	month	nnt2
,	,	y
had	have	vhd
"	"	y
a	a	at1
friend	friend	nn1
or	or	cc
relative	relative	jj_nn1
or	or	cc
anyone	anyone	pn1
else	else	rr
express	express	vv0_jj@
concern	concern	nn1
"	"	y
about	about	ii
their	their	appge
use	use	nn1
of	of	io
cannabis	cannabis	nn1
(	(	y
2	2	mc
points	point	nn2_vvz
)	)	y
for	for	if
a	a	at1
total	total	jj
score	score	nn1
of	of	io
5	5	mc
points	point	nn2
.	.	y
Similarly	similarly	rr
we	we	ppis2
use	use	vv0
the	the	at
term	term	nn1
"	"	y
hazardous	hazardous	jj
tobacco	tobacco	nn1
use	use	nn1_vv0
"	"	y
to	to	to
refer	refer	vvi
to	to	ii
those	those	dd2
who	who	pnqs
have	have	vh0
moderate	moderate	jj
to	to	ii
high	high	jj
risk	risk	nn1
for	for	if
tobacco	tobacco	nn1
(	(	y
a	a	at1
score	score	nn1
of	of	io
4	4	mc
or	or	cc
higher	high	jjr
for	for	if
tobacco	tobacco	nn1
use	use	nn1
)	)	y
.	.	y
For	for	if
the	the	at
analysis	analysis	nn1
examining	examine	vvg
health	health	nn1
conditions	condition	nn2
by	by	ii
any	any	dd
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
,	,	y
we	we	ppis2
included	include	vvd
those	those	dd2
who	who	pnqs
were	be	vbdr
hazardous	hazardous	jj
drinkers	drinker	nn2
(	(	y
based	base	vvn
on	on	ii
the	the	at
AUDIT	audit	nn1
)	)	y
or	or	cc
hazardous	hazardous	jj
drug	drug	nn1
or	or	cc
tobacco	tobacco	nn1
users	user	nn2
(	(	y
based	base	vvn
on	on	ii
the	the	at
ASSIST	assist	vv0
)	)	y
.	.	y
HEALTH	health	nn1
CONDITIONS	condition	nn2
The	the	at
instrument	instrument	nn1
also	also	rr
included	include	vvn_vvd
questions	question	nn2
about	about	ii
an	a	at1
array	array	nn1
of	of	io
medical	medical	jj
conditions	condition	nn2
,	,	y
such	such	ii21
as	as	ii22
whether	whether	csw
the	the	at
condition	condition	nn1
had	have	vhd
ever	ever	rr
been	be	vbn
diagnosed	diagnose	vvn
by	by	ii
a	a	at1
doctor	doctor	nn1
(	(	y
i.e.	ie	rex
,	,	y
lifetime	lifetime	nnt1
prevalence	prevalence	nn1
)	)	y
,	,	y
and	and	cc
,	,	y
for	for	if
those	those	dd2
reporting	report	vvg
in	in	ii
the	the	at
affirmative	affirmative	nn1_jj
,	,	y
whether	whether	csw
they	they	pphs2
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
.	.	y
We	we	ppis2
did	do	vdd
not	not	xx
ask	ask	vvi
about	about	ii
HIV/AIDS	hiv/aids	fu
due	due	ii21
to	to	ii22
confidentiality	confidentiality	nn1
concerns	concern	nn2_vvz
and	and	cc
because	because	cs
the	the	at
low	low	jj
rate	rate	nn1
of	of	io
HIV	hiv	np1
testing	testing	nn1_vvg
in	in	ii
this	this	dd1
population	population	nn1
would	would	vm
make	make	vvi
results	result	nn2
unreliable	unreliable	jj
.	.	y
PROCEDURES	procedure	nn2
Interviewers	interviewer	nn2
recruited	recruit	vvn_jj@_vvd@
patients	patient	nn2
as	as	csa
they	they	pphs2
waited	wait	vvd
for	for	if
their	their	appge
medical	medical	jj
visit	visit	nn1
.	.	y
Patients	patient	nn2
were	be	vbdr
interviewed	interview	vvn
in	in	ii_rr21
private	private	jj_rr22
rooms	room	nn2
by	by	ii
a	a	at1
trained	trained	jj@
research	research	nn1
assistant	assistant	nn1
,	,	y
who	who	pnqs
was	be	vbdz
matched	match	vvn
to	to	ii
the	the	at
patient	patient	nn1_jj
for	for	if
gender	gender	nn1
and	and	cc
language	language	nn1
.	.	y
Data	data	nn
were	be	vbdr
entered	enter	vvn
by	by	ii
the	the	at
research	research	nn1
assistants	assistant	nn2
on	on	ii
handheld	hand-held	jj
computers	computer	nn2
.	.	y
After	after	cs_ii
the	the	at
interview	interview	nn1
,	,	y
respondents	respondent	nn2
were	be	vbdr
given	give	vvn
a	a	at1
list	list	nn1
of	of	io
referral	referral	nn1
resources	resource	nn2
(	(	y
e.g.	eg	rex
,	,	y
substance	substance	nn1
use	use	nn1_vv0
treatment	treatment	nn1
,	,	y
HIV	hiv	np1
testing	testing	nn1_vvg
,	,	y
psychiatric	psychiatric	jj
services	service	nn2
)	)	y
to	to	to
use	use	vvi
if	if	csw@_cs
they	they	pphs2
wished	wish	vvd
to	to	to
seek	seek	vvi
help	help	nn1_vv0
for	for	if
anything	anything	pn1
addressed	address	vvd_vvn
by	by	ii
the	the	at
interview	interview	nn1
,	,	y
and	and	cc
those	those	dd2
who	who	pnqs
had	have	vhd
reported	report	vvn
hazardous	hazardous	jj
behavior	behavior	nn1
were	be	vbdr
encouraged	encourage	vvn
to	to	to
do	do	vdi
so	so	rr
by	by	ii
the	the	at
field	field	nn1
worker	worker	nn1
.	.	y
ANALYSES	analyse	vvz_nn2
The	the	at
interview	interview	nn1
data	data	nn
were	be	vbdr
weighted	weight	vvn
to	to	to
account	account	vvi
for	for	if
clustering	clustering	nn1
,	,	y
the	the	at
over-sampling	over-sampling	nn1
of	of	io
18-24	18-24	mcmc
year	year	nnt1
olds	old	nn2
,	,	y
non-response	nonresponse	nn1
differences	difference	nn2
(	(	y
by	by	ii
gender	gender	nn1
,	,	y
age	age	nn1_vv0@
,	,	y
and	and	cc
race	race	nn1
)	)	y
within	within	ii
clinics	clinic	nn2
,	,	y
and	and	cc
the	the	at
size	size	nn1
of	of	io
clinics	clinic	nn2
proportional	proportional	jj
to	to	ii
the	the	at
full	full	jj
population	population	nn1
served	serve	vvn
by	by	ii
Cape	cape	np1
Town	town	np1
's	's	ge
Community	community	nn1
Health	health	nn1
Centres	centre	nn2
.	.	y
The	the	at
overall	overall	jj_nn1
weighted	weighted	jj
sample	sample	nn1
size	size	nn1
was	be	vbdz
normalized	normalize	vvn@
to	to	ii
the	the	at
observed	observed	jj@
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
median=0.34		fo
;	;	y
inter-quartile	inter-quartile	jj_nn1
range	range	nn1
=	=	fo
0.14-0.72		mcmc
)	)	y
.	.	y
The	the	at
recruitment	recruitment	nn1
rate	rate	nn1
was	be	vbdz
43%	43%	nnu
;	;	y
non-response	nonresponse	nn1
was	be	vbdz
due	due	jj_rr%
primarily	primarily	rr
to	to	ii
attempts	attempt	nn2
to	to	to
recruit	recruit	vvi
patients	patient	nn2
who	who	pnqs
,	,	y
when	when	cs_rrq
sought	seek	vvn
by	by	ii
the	the	at
interviewers	interviewer	nn2
,	,	y
were	be	vbdr
not	not	xx
available	available	jj
.	.	y
Depending	depending	ii21
on	on	ii22
physician	physician	nn1
staffing	staffing	nn1
patterns	pattern	nn2
,	,	y
some	some	dd
clinics	clinic	nn2
had	have	vhd
shorter	short	jjr
waiting	waiting	nn1@_jj@
periods	period	nn2
;	;	y
some	some	dd
also	also	rr
had	have	vhd_vhn@
fewer	fewer	dar
interview	interview	nn1
rooms	room	nn2
,	,	y
so	so	cs@_rr
that	that	dd1_cst_rg%
selected	selected	jj
patients	patient	nn2
would	would	vm
already	already	rr
have	have	vhi
seen	see	vvn
a	a	at1
practitioner	practitioner	nn1
and	and	cc
left	leave	vvn
the	the	at
clinic	clinic	nn1
.	.	y
In	in	ii
the	the	at
clinics	clinic	nn2
,	,	y
patients	patient	nn2
are	be	vbr
seen	see	vvn
on	on	ii
a	a	at1
first-come	first-come	jj_nn1@
,	,	y
first-serve	first-serve	jj
basis	basis	nn1
.	.	y
Since	since	cs
the	the	at
recruitment	recruitment	nn1
rates	rate	nn2
were	be	vbdr
primarily	primarily	rr
related	relate	vvn_vvd
to	to	ii
practical	practical	jj
arrangements	arrangement	nn2
within	within	ii
the	the	at
clinics	clinic	nn2
,	,	y
it	it	pph1
is	be	vbz
unlikely	unlikely	jj
that	that	cst
there	there	ex
is	be	vbz
systematic	systematic	jj
bias	bias	nn1
in	in	ii31
terms	terms	ii32
of	of	ii33
the	the	at
variables	variable	nn2
of	of	io
interest	interest	nn1
(	(	y
or	or	cc
of	of	io
sample	sample	nn1
characteristics	characteristic	nn2
such	such	ii21
as	as	ii22
race	race	nn1
or	or	cc
gender	gender	nn1
)	)	y
.	.	y
(	(	y
For	for	if
details	detail	nn2
on	on	ii
recruitment	recruitment	nn1
see	see	vv0
Ward	ward	np1
,	,	y
in	in	ii
press	press	nn1
.	.	y
)	)	y
Our	our	appge
weights	weight	nn2
adjust	adjust	vv0
for	for	if
differences	difference	nn2
between	between	ii
the	the	at
sample	sample	nn1
and	and	cc
population	population	nn1
in	in	ii
the	the	at
clinics	clinic	nn2
represented	represent	vvn_vvd
.	.	y
We	we	ppis2
used	use	vvd
SAS	sa	np1
Version	version	nn1
9	9	mc
Proc	proc	np1
Surveyfreq		np1
and	and	cc
SurveyLogistic	surveylogistic	jj_np1
procedures	procedure	nn2
to	to	to
obtain	obtain	vvi
percentages	percentage	nn2
,	,	y
calculate	calculate	vv0
confidence	confidence	nn1
intervals	interval	nn2
,	,	y
and	and	cc
perform	perform	vv0
logistic	logistic	jj
regression	regression	nn1
models	model	nn2
;	;	y
these	these	dd2
procedures	procedure	nn2
take	take	vv0
into	into	ii
account	account	nn1_vv0
the	the	at
weights	weight	nn2
,	,	y
stratification	stratification	nn1
,	,	y
and	and	cc
cluster	cluster	vv0_nn1
design	design	nn1
of	of	io
our	our	appge
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
users	user	nn2
versus	versus	ii
non-hazerdous	non-hazerdous	jj
users	user	nn2
,	,	y
and	and	cc
to	to	to
obtain	obtain	vvi
odds	odds	nn2
ratios	ratio	nn2
we	we	ppis2
conducted	conduct	vvd
a	a	at1
logistic	logistic	jj
regression	regression	nn1
(	(	y
controlling	control	vvg_jj@
age	age	nn1
and	and	cc
gender	gender	nn1
)	)	y
model	model	nn1_vv0@
for	for	if
each	each	dd1
health	health	nn1
condition	condition	nn1
(	(	y
as	as	csa_ii
the	the	at
criterion	criteria	nn1
variable	variable	nn1
)	)	y
using	use	vvg
the	the	at
relevant	relevant	jj
substance	substance	nn1
use	use	nn1_vv0
variable	variable	nn1
(	(	y
i.e.	ie	rex
,	,	y
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
hazardous	hazardous	jj
drug	drug	nn1
use	use	nn1_vv0
,	,	y
or	or	cc
tobacco	tobacco	nn1
use	use	nn1
)	)	y
as	as	ii_csa
the	the	at
independent	independent	jj
variable	variable	nn1
.	.	y
To	to	to
calculate	calculate	vvi
age	age	nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
for	for	if
each	each	dd1
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
health	health	nn1
condition	condition	nn1
by	by	ii
patients	patient	nn2
who	who	pnqs
met	meet	vvd
criteria	criteria	nn2
for	for	if
moderate	moderate	jj
to	to	ii
high	high	jj
risk	risk	nn1
substance	substance	nn1
use	use	nn1_vv0
versus	versus	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
,	,	y
we	we	ppis2
used	use	vvd
logistic	logistic	jj
regression	regression	nn1
models	model	nn2
.	.	y
We	we	ppis2
estimated	estimate	vvd
the	the	at
age	age	nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
of	of	io
each	each	dd1
outcome	outcome	nn1
in	in	ii
hazardous	hazardous	jj
users	user	nn2
versus	versus	ii
others	others	nn2
in	in	ii
the	the	at
sample	sample	nn1
based	base	vvn
on	on	ii
the	the	at
age	age	nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
odds	odds	nn2
ratios	ratio	nn2
(	(	y
from	from	ii
SurveyLogistic		np1
)	)	y
.	.	y
Due	due	ii21
to	to	ii22
missing	missing	jj_vvg
data	data	nn
,	,	y
Ns	ns	np1
for	for	if
analyses	analysis	nn2
ranged	range	vvn_vvd
from	from	ii
2543	2543	mc
to	to	ii
2618	2618	mc
.	.	y
Due	due	ii21
to	to	ii22
the	the	at
self-report	self-report	jj_nn1
nature	nature	nn1
of	of	io
the	the	at
medical	medical	jj
conditions	condition	nn2
data	data	nn
,	,	y
we	we	ppis2
focus	focus	vv0
here	here	rl
more	more	dar
on	on	ii
the	the	at
relative	relative	jj_nn1
odds	odds	nn2
of	of	io
medical	medical	jj
conditions	condition	nn2
(	(	y
i.e.	ie	rex
,	,	y
the	the	at
odds	odds	nn2
ratios	ratio	nn2
)	)	y
than	than	csn
the	the	at
absolute	absolute	jj
age	age	nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
.	.	y
No	no	at
adjustments	adjustment	nn2
were	be	vbdr
made	make	vvn
for	for	if
multiple	multiple	jj_nn1
comparisons	comparison	nn2
(	(	y
Rothman	rothman	np1_nn1
,	,	y
1990	1990	mc
)	)	y
.	.	y
RESULTS	result	nn2
SAMPLE	sample	vv0@_nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
of	of	io
the	the	at
weighted	weighted	jj
sample	sample	nn1
was	be	vbdz
female	female	jj_nn1
;	;	y
about	about	rg
nine	nine	mc
in	in	ii
ten	ten	mc
(	(	y
91%	91%	nnu
)	)	y
were	be	vbdr
over	over	ii_rp
age	age	nn1
25	25	mc
.	.	y
The	the	at
sample	sample	nn1
was	be	vbdz
largely	largely	rr
black	black	jj
(	(	y
59.5%	59.5%	fo
)	)	y
and	and	cc
colored	color	vvd_jj@_vvn@
(	(	y
39.1%	39.1%	fo
)	)	y
;	;	y
0.1%	0.1%	fo
were	be	vbdr
Indian	indian	jj
and	and	cc
1.3%	1.3%	fo
were	be	vbdr
white	white	jj
.	.	y
Forty-four	forty-four	mc
percent	percent	nnu
of	of	io
participants	participant	nn2
were	be	vbdr
married	married	jj
,	,	y
15%	15%	nnu
were	be	vbdr
widowed	widowed	jj_vvn@
,	,	y
11%	11%	nnu
were	be	vbdr
separated	separate	vvn_jj
or	or	cc
divorced	divorced	jj_vvd_vvn
and	and	cc
29%	29%	nnu
were	be	vbdr
never	never	rr
married	married	jj
.	.	y
A	a	at1
majority	majority	nn1
(	(	y
58%	58%	nnu
)	)	y
spoke	speak	vvd
isiXhosa	isixhosa	nn1
;	;	y
38%	38%	nnu
spoke	speak	vvd
Afrikaans	afrikaans	jj_nn1
and	and	cc
24%	24%	nnu
spoke	speak	vvd
English	english	nn1_jj
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
religion	religion	nn1
,	,	y
85.1%	85.1%	fo
were	be	vbdr
Christian	christian	jj
,	,	y
8.7%	8.7%	fo
were	be	vbdr
Muslim	muslim	jj
,	,	y
2.5%	2.5%	fo
were	be	vbdr
of	of	io
some	some	dd
other	other	jj
religion	religion	nn1
,	,	y
and	and	cc
3.7%	3.7%	fo
reported	report	vvd_vvn
no	no	at
religion	religion	nn1
.	.	y
Thirty-seven	thirty-seven	mc
percent	percent	nnu
had	have	vhd
completed	complete	vvn
grade	grade	nn1_vv0
six	six	mc
or	or	cc
had	have	vhd
less	less	dar
education	education	nn1
and	and	cc
only	only	rr_jj
2.5%	2.5%	fo
had	have	vhd
completed	complete	vvn
technical	technical	jj
training	training	nn1
or	or	cc
at	at	rr21
least	least	rr22
some	some	dd
college	college	nn1
.	.	y
The	the	at
most	most	rgt
common	common	jj
current	current	jj
self-reported	self-reported	jj_nn1
health	health	nn1
conditions	condition	nn2
were	be	vbdr
hypertension	hypertension	nn1
(	(	y
37%	37%	nnu
)	)	y
,	,	y
arthritis	arthritis	nn1
(	(	y
23%	23%	nnu
)	)	y
,	,	y
diabetes	diabetes	nn1
(	(	y
15%	15%	nnu
)	)	y
,	,	y
migraine	migraine	vv0_nn1
headaches	headache	nn2
(	(	y
14%	14%	nnu
)	)	y
,	,	y
asthma	asthma	nn1
(	(	y
14%	14%	nnu
)	)	y
,	,	y
depression	depression	nn1
or	or	cc
anxiety	anxiety	nn1
(	(	y
13%	13%	nnu
)	)	y
,	,	y
heart	heart	nn1
disease	disease	nn1
(	(	y
9%	9%	nnu
)	)	y
,	,	y
epilepsy	epilepsy	nn1
(	(	y
8%	8%	nnu
)	)	y
,	,	y
hay	hay	nn1
fever	fever	nn1
(	(	y
6%	6%	nnu
)	)	y
,	,	y
stomach	stomach	nn1
ulcer	ulcer	nn1
(	(	y
5%	5%	nnu
)	)	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
reported	report	vvn_vvd_jj@
current	current	jj
TB	tb	nn1
,	,	y
4%	4%	nnu
reported	report	vvd_vvn
Chronic	chronic	jj
Obstructive	obstructive	jj
Pulmonary	pulmonary	jj
Disease	disease	nn1
(	(	y
COPD	copd	nn1
)	)	y
,	,	y
3%	3%	nnu
reported	reported	jj@_vvn_vvd
bladder	bladder	nn1
infections	infection	nn2
,	,	y
and	and	cc
1.5%	1.5%	fo
reported	reported	jj@_vvn_vvd
anemia	anemia	nn1
.	.	y
Of	of	io
men	man	nn2
,	,	y
1.5%	1.5%	fo
reported	report	vvn_vvd_jj@
current	current	jj
benign	benign	jj
prostate	prostate	nn1
problems	problem	nn2
.	.	y
CHARACTERISTICS	characteristic	nn2
OF	of	io
HAZARDOUS	hazardous	jj
SUBSTANCE	substance	nn1
USERS	user	nn2
Those	those	dd2
who	who	pnqs
screened	screen	vvd
positive	positive	jj
for	for	if
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
drug	drug	nn1
,	,	y
or	or	cc
tobacco	tobacco	nn1
use	use	nn1
compared	compare	vvn
to	to	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
were	be	vbdr
less	less	rgr
likely	likely	jj
to	to	to
be	be	vbi
women	woman	nn2
(	(	y
40%	40%	nnu
vs.	vs	ii
76%	76%	nnu
,	,	y
respectively	respectively	rr
)	)	y
,	,	y
less	less	rgr
likely	likely	jj
to	to	to
be	be	vbi
widowed	widow	vvn@_jj
(	(	y
11%	11%	nnu
versus	versus	ii
18%	18%	nnu
)	)	y
,	,	y
and	and	cc
less	less	rgr
likely	likely	jj
to	to	to
be	be	vbi
Christian	christian	jj
(	(	y
81%	81%	nnu
versus	versus	ii
88%	88%	nnu
)	)	y
.	.	y
They	they	pphs2
were	be	vbdr
also	also	rr
more	more	rgr
likely	likely	jj
to	to	to
lack	lack	vvi
piped	piped	jj@
water	water	nn1
in	in	ii
their	their	appge
house	house	nn1
or	or	cc
on	on	ii
site	site	nn1
(	(	y
8%	8%	nnu
versus	versus	ii
5%	5%	nnu
)	)	y
.	.	y
(	(	y
For	for	if
more	more	dar
details	detail	nn2
on	on	ii
characteristics	characteristic	nn2
of	of	io
hazardous	hazardous	jj
drug	drug	nn1
and	and	cc
alcohol	alcohol	nn1
users	user	nn2
,	,	y
see	see	vv0
Ward	ward	np1
,	,	y
in	in	ii
press	press	nn1
.	.	y
)	)	y
RELATIONSHIPS	relationship	nn2
BETWEEN	between	ii
HAZARDOUS	hazardous	jj
ALCOHOL	alcohol	nn1
,	,	y
DRUG	drug	nn1
,	,	y
AND	and	cc
TOBACCO	tobacco	nn1
USE	use	vv0_nn1
A	a	at1@_zz1
total	total	nn1_jj
of	of	io
12.3%	12.3%	fo
of	of	io
hazardous	hazardous	jj
drinkers	drinker	nn2
were	be	vbdr
also	also	rr
hazardous	hazardous	jj
users	user	nn2
of	of	io
other	other	jj
drugs	drug	nn2
;	;	y
65%	65%	nnu
were	be	vbdr
hazardous	hazardous	jj
tobacco	tobacco	nn1
users	user	nn2
(	(	y
not	not	xx
shown	show	vvn
)	)	y
.	.	y
Of	of	io
hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
,	,	y
57%	57%	nnu
were	be	vbdr
hazardous	hazardous	jj
drinkers	drinker	nn2
and	and	cc
64%	64%	nnu
were	be	vbdr
hazardous	hazardous	jj
tobacco	tobacco	nn1
users	user	nn2
.	.	y
Thirty-six	thirty-six	mc
percent	percent	nnu
of	of	io
hazardous	hazardous	jj
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
hazardous	hazardous	jj
users	user	nn2
of	of	io
other	other	jj
drugs	drug	nn2
.	.	y
HEALTH	health	nn1
CONDITIONS	condition	nn2
IN	in	ii
HAZARDOUS	hazardous	jj
DRINKERS	drinker	nn2
.	.	y
Age	age	nn1_vv0@
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
of	of	io
health	health	nn1
conditions	condition	nn2
by	by	ii
hazardous	hazardous	jj
drinking	drinking	nn1
status	status	nn1
,	,	y
along	along	ii21
with	with	ii22
odds	odds	nn2
ratios	ratio	nn2
of	of	io
reporting	report	vvg
each	each	dd1
condition	condition	nn1
comparing	compare	vvg
hazardous	hazardous	jj
drinkers	drinker	nn2
to	to	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
screen	screen	vvi
positive	positive	jj
for	for	if
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
are	be	vbr
shown	show	vvn
in	in	ii
Table	table	nn1
2	2	mc
.	.	y
Compared	compare	vvn
to	to	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
screen	screen	vvi
positive	positive	jj
,	,	y
hazardous	hazardous	jj
drinkers	drinker	nn2
had	have	vhd
higher	high	jjr
lifetime	lifetime	nnt1
odds	odds	nn2
of	of	io
COPD	copd	nn1
and	and	cc
bladder	bladder	nn1
infections	infection	nn2
.	.	y
Hazardous	hazardous	jj
drinkers	drinker	nn2
also	also	rr
had	have	vhn@_vhd
higher	high	jjr
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
odds	odds	nn2
of	of	io
liver	liver	nn1
cirrhosis	cirrhosis	nn1
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
pain-related	pain-related	jj_nn1
diagnoses	diagnosis	nn2_vvz
,	,	y
hazardous	hazardous	jj
drinkers	drinker	nn2
had	have	vhd
lower	low	jjr_rrr@
current	current	jj_nn1@
and	and	cc
lifetime	lifetime	nnt1
odds	odds	nn2
of	of	io
arthritis	arthritis	nn1
,	,	y
and	and	cc
there	there	ex
was	be	vbdz
a	a	at1
trend	trend	nn1
(	(	y
though	though	cs
not	not	xx
significant	significant	jj
)	)	y
for	for	if
higher	high	jjr
current	current	jj
odds	odds	nn2
of	of	io
migraine	migraine	nn1
in	in	ii
hazardous	hazardous	jj
drinkers	drinker	nn2
.	.	y
Findings	finding	nn2
regarding	regarding	ii_vvg
cardiovascular	cardiovascular	jj
disease	disease	nn1
were	be	vbdr
mainly	mainly	rr
consistent	consistent	jj
--		zz
hazardous	hazardous	jj
drinkers	drinker	nn2
had	have	vhd
lower	low	jjr
lifetime	lifetime	nnt1
odds	odds	nn2
of	of	io
stroke	stroke	nn1
and	and	cc
hypertension	hypertension	nn1
and	and	cc
lower	low	jjr
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
odds	odds	nn2
of	of	io
heart	heart	nn1
disease	disease	nn1
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
infectious	infectious	jj
diseases	disease	nn2
,	,	y
hazardous	hazardous	jj
drinkers	drinker	nn2
had	have	vhd
lower	low	jjr
lifetime	lifetime	nnt1
odds	odds	nn2
of	of	io
Hepatitis	hepatitis	np1_nn1
and	and	cc
had	have	vhd_vhn@
higher	high	jjr
lifetime	lifetime	nnt1
odds	odds	nn2
of	of	io
TB	tb	nn1
but	but	ccb
lower	low	jjr_vv0@_rrr@
current	current	jj
odds	odds	nn2
.	.	y
Finally	finally	rr
,	,	y
hazardous	hazardous	jj
drinkers	drinker	nn2
had	have	vhd
lower	low	jjr
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
odds	odds	nn2
of	of	io
thyroid	thyroid	jj_nn1
disease	disease	nn1
.	.	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
reporting	report	vvg_nn1_jj@
depression	depression	nn1
and	and	cc
anxiety	anxiety	nn1
.	.	y
To	to	to
further	far	rrr
examine	examine	vvi
the	the	at
negative	negative	jj
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
some	some	dd
medical	medical	jj
conditions	condition	nn2
,	,	y
we	we	ppis2
conducted	conduct	vvd
post-hoe	post-hoe	jj_nn1
analyses	analysis	nn2
.	.	y
These	these	dd2
analyses	analysis	nn2
were	be	vbdr
informed	inform	vvn
by	by	ii
research	research	nn1
showing	show	vvg
that	that	cst_dd1
both	both	rr
former	former	da
drinkers	drinker	nn2
and	and	cc
lifelong	lifelong	jj
abstainers	abstainer	nn2
have	have	vh0
unique	unique	jj
health	health	nn1
and	and	cc
lifestyle	lifestyle	nn1
characteristics	characteristic	nn2
which	which	ddq
make	make	vv0
them	them	ppho2
an	a	at1
inappropriate	inappropriate	jj
comparison	comparison	nn1
group	group	nn1
for	for	if
studies	study	nn2
of	of	io
alcohol	alcohol	nn1
use	use	nn1
and	and	cc
health	health	nn1
(	(	y
Green	green	np1@_jj
&;		null
Polen	polen	np1_nn1
,	,	y
2001	2001	mc
;	;	y
Mertens	mertens	np1
,	,	y
Moos	moos	np1_nn2
,	,	y
&;		null
Brennan	brennan	np1
,	,	y
1996	1996	mc
)	)	y
.	.	y
We	we	ppis2
re-ran	re-ran	vvd
the	the	at
logistic	logistic	jj
regression	regression	nn1
models	model	nn2
after	after	ii
removing	remove	vvg
abstainers	abstainer	nn2
(	(	y
abstained	abstain	vvn@_vvd
in	in	ii
the	the	at
past	past	jj
three	three	mc
months	month	nnt2
or	or	cc
who	who	pnqs
were	be	vbdr
lifetime	lifetime	nnt1
abstainers	abstainer	nn2
)	)	y
from	from	ii
the	the	at
reference	reference	nn1
group	group	nn1
(	(	y
not	not	xx
shown	show	vvn
)	)	y
.	.	y
In	in	ii
these	these	dd2
models	model	nn2
,	,	y
the	the	at
negative	negative	jj
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
arthritis	arthritis	nn1
(	(	y
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
)	)	y
,	,	y
hypertension	hypertension	nn1
(	(	y
lifetime	lifetime	nnt1
)	)	y
,	,	y
current	current	jj
TB	tb	nn1
,	,	y
COPD	copd	nn1
(	(	y
lifetime	lifetime	nnt1
)	)	y
,	,	y
Hepatitis	hepatitis	np1_nn1
A	a	zz1
(	(	y
lifetime	lifetime	nnt1
)	)	y
,	,	y
were	be	vbdr
no	no	rr21
longer	long	rr22
significant	significant	jj
.	.	y
Further	far	rrr_jjr
,	,	y
the	the	at
positive	positive	jj
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
reporting	report	vvg
ever	ever	rr
having	have	vhg
a	a	at1
bladder	bladder	nn1
infection	infection	nn1
,	,	y
and	and	cc
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
liver	liver	nn1
disease	disease	nn1
were	be	vbdr
no	no	rr21
longer	long	rr22
significant	significant	jj
.	.	y
On	on	ii
the	the	at
other	other	jj
hand	hand	nn1
,	,	y
the	the	at
relationships	relationship	nn2
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
higher	high	jjr
odds	odds	nn2
of	of	io
STDs	std	nn2
(	(	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
lifetime	lifetime	nnt1
)	)	y
and	and	cc
bladder	bladder	nn1
infection	infection	nn1
(	(	y
current	current	jj_nn1@
)	)	y
became	become	vvd
significant	significant	jj
.	.	y
Other	other	jj
results	result	nn2
remained	remain	vvd
the	the	at
same	same	da
.	.	y
We	we	ppis2
also	also	rr
re-ran	re-ran	vvd
the	the	at
models	model	nn2
controlling	control	vvg
for	for	if
social	social	jj
class	class	nn1
variables	variable	nn2
(	(	y
employment	employment	nn1
status	status	nn1
,	,	y
head	head	nn1
of	of	io
household	household	nn1
employment	employment	nn1
status	status	nn1
,	,	y
and	and	cc
education	education	nn1
status	status	nn1
)	)	y
(	(	y
not	not	xx
shown	show	vvn
)	)	y
.	.	y
The	the	at
pattern	pattern	nn1
of	of	io
results	result	nn2
did	do	vdd
not	not	xx
change	change	vvi
when	when	rrq_cs
including	including	ii_vvg@
these	these	dd2
variables	variable	nn2
in	in	ii
the	the	at
models	model	nn2
.	.	y
HEALTH	health	nn1
CONDITIONS	condition	nn2
IN	in	ii
HAZARDOUS	hazardous	jj
DRUG	drug	nn1
USERS	user	nn2
.	.	y
Table	table	nn1
3	3	mc
presents	present	vvz_nn2
age-	age-	jj_nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
of	of	io
health	health	nn1
conditions	condition	nn2
and	and	cc
odds	odds	nn2
ratios	ratio	nn2
from	from	ii
logistic	logistic	jj
regression	regression	nn1
models	model	nn2
comparing	compare	vvg
hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
(	(	y
i.e.	ie	rex
,	,	y
moderate	moderate	jj_vv0@
to	to	ii
high	high	jj
risk	risk	nn1
use	use	nn1
of	of	io
drugs	drug	nn2
other	other	ii21
than	than	ii22
alcohol	alcohol	nn1
and	and	cc
tobacco	tobacco	nn1
)	)	y
versus	versus	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
screen	screen	vvi
positive	positive	jj
for	for	if
hazardous	hazardous	jj
drug	drug	nn1
use	use	nn1
.	.	y
Hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
odds	odds	nn2
of	of	io
migraine	migraine	nn1
,	,	y
but	but	ccb
there	there	ex
were	be	vbdr
no	no	at
differences	difference	nn2
in	in	ii
another	another	dd1
pain-related	pain-related	jj_nn1
condition	condition	nn1
--		nn1_jj
arthritis	arthritis	nn1
.	.	y
Similar	similar	jj
to	to	ii
the	the	at
findings	finding	nn2
on	on	ii
hazardous	hazardous	jj
drinkers	drinker	nn2
,	,	y
hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
had	have	vhd
higher	high	jjr_rrr@
current	current	jj
odds	odds	nn2
of	of	io
liver	liver	nn1
disease	disease	nn1
.	.	y
Hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
also	also	rr
had	have	vhn@_vhd
higher	high	jjr
lifetime	lifetime	nnt1
odds	odds	nn2
of	of	io
stomach	stomach	nn1
ulcers	ulcer	nn2
,	,	y
and	and	cc
higher	high	jjr
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
odds	odds	nn2
of	of	io
bladder	bladder	nn1
infections	infection	nn2
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
infectious	infectious	jj
diseases	disease	nn2
,	,	y
hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
and	and	cc
Hepatitis	hepatitis	np1_nn1
B	b	zz1_np1@
,	,	y
They	they	pphs2
were	be	vbdr
more	more	rgr
likely	likely	jj
to	to	to
have	have	vhi
current	current	jj
COPD	copd	nn1
,	,	y
although	although	cs
this	this	dd1
relationship	relationship	nn1
only	only	rr
approached	approach	vvn_vvd
statistical	statistical	jj
significance	significance	nn1
(	(	y
p	xx_p	zz1
=	=	fo
.07	.07	mc
)	)	y
.	.	y
Regarding	regarding	ii_vvg
mental	mental	jj
health	health	nn1
problems	problem	nn2
,	,	y
hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
odds	odds	nn2
of	of	io
self-reported	self-reported	jj_nn1
depression	depression	nn1
or	or	cc
anxiety	anxiety	nn1
.	.	y
There	there	ex
were	be	vbdr
no	no	at
differences	difference	nn2
by	by	ii
hazardous	hazardous	jj
drug	drug	nn1
use	use	nn1_vv0
for	for	if
cardiovascular	cardiovascular	jj
diseases	disease	nn2
.	.	y
HEALTH	health	nn1
CONDITIONS	condition	nn2
IN	in	ii
TOBACCO	tobacco	nn1
USERS	user	nn2
Table	table	nn1
4	4	mc
presents	present	vvz_nn2
age-	age-	jj_nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
and	and	cc
odds	odds	nn2
ratios	ratio	nn2
of	of	io
health	health	nn1
conditions	condition	nn2
for	for	if
those	those	dd2
who	who	pnqs
screened	screen	vvd
positive	positive	jj
for	for	if
hazardous	hazardous	jj
tobacco	tobacco	nn1
use	use	nn1_vv0
versus	versus	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
respiratory	respiratory	jj
diseases	disease	nn2
,	,	y
hazardous	hazardous	jj
tobacco	tobacco	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
odds	odds	nn2
of	of	io
,	,	y
current	current	jj
hay	hay	nn1
fever	fever	nn1
,	,	y
lifetime	lifetime	nnt1
asthma	asthma	nn1
,	,	y
and	and	cc
lifetime	lifetime	nnt1
chronic	chronic	jj
bronchitis	bronchitis	nn1
.	.	y
For	for	if
pain-related	pain-related	jj_nn1
diagnoses	diagnosis	nn2_vvz
,	,	y
there	there	ex
was	be	vbdz
no	no	at
difference	difference	nn1
for	for	if
arthritis	arthritis	nn1
,	,	y
but	but	ccb
hazardous	hazardous	jj
tobacco	tobacco	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
odds	odds	nn2
of	of	io
self-reported	self-reported	jj
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
migraines	migraine	nn2
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
cardiovascular	cardiovascular	jj
diseases	disease	nn2
,	,	y
hazardous	hazardous	jj
tobacco	tobacco	nn1
users	user	nn2
had	have	vhd
lower	low	jjr
odds	odds	nn2
of	of	io
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
hypertension	hypertension	nn1
and	and	cc
heart	heart	nn1
disease	disease	nn1
and	and	cc
no	no	at_uh
statistically	statistically	rr
significant	significant	jj
differences	difference	nn2
for	for	if
stroke	stroke	nn1
.	.	y
They	they	pphs2
had	have	vhd
a	a	at1
higher	high	jjr
odds	odds	nn2
of	of	io
reporting	report	vvg_jj@_nn1
lifetime	lifetime	nnt1
TB	tb	nn1
but	but	ccb
did	do	vdd
not	not	xx
differ	differ	vvi
with	with	ii31
regard	regard	ii32
to	to	ii33
other	other	jj
infectious	infectious	jj
diseases	disease	nn2
.	.	y
Tobacco	tobacco	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
lifetime	lifetime	nnt1
bladder	bladder	nn1
infection	infection	nn1
and	and	cc
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
anemia	anemia	nn1
,	,	y
current	current	jj
STDs	std	nn2
,	,	y
and	and	cc
lifetime	lifetime	nnt1
prostate	prostate	nn1
problems	problem	nn2
.	.	y
HEALTH	health	nn1
CONDITIONS	condition	nn2
BY	by	ii
ANY	any	dd
HAZARDOUS	hazardous	jj
USE	use	nn1
--		nn1_jj
ALCOHOL	alcohol	nn1
,	,	y
TOBACCO	tobacco	nn1
,	,	y
OR	or	cc
OTHER	other	jj
DRUGS	drug	nn2
Table	table	nn1
5	5	mc
presents	present	vvz_nn2
age-	age-	jj_nn1
and	and	cc
gender-adjusted	gender-adjusted	jj_nn1
prevalence	prevalence	nn1
and	and	cc
odds	odds	nn2
ratios	ratio	nn2
of	of	io
health	health	nn1
conditions	condition	nn2
by	by	ii
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
(	(	y
i.e.	ie	rex
,	,	y
any	any	dd
hazardous	hazardous	jj
alcohol	alcohol	nn1
,	,	y
drug	drug	nn1
or	or	cc
tobacco	tobacco	nn1
use	use	nn1
)	)	y
versus	versus	ii
none	none	pn
.	.	y
Regarding	regarding	ii_vvg
respiratory	respiratory	jj
disorders	disorder	nn2
,	,	y
those	those	dd2
who	who	pnqs
had	have	vhd
hazardous	hazardous	jj
use	use	nn1
of	of	io
any	any	dd
substance	substance	nn1
had	have	vhd
higher	high	jjr
odds	odds	nn2
of	of	io
current	current	jj
hay	hay	nn1
fever	fever	nn1
and	and	cc
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
asthma	asthma	nn1
and	and	cc
lifetime	lifetime	nnt1
bronchitis	bronchitis	nn1
.	.	y
With	with	ii31
regard	regard	ii32
to	to	ii33
pain-related	pain-related	jj_nn1
disorders	disorder	nn2
,	,	y
hazardous	hazardous	jj
substance	substance	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
odds	odds	nn2
of	of	io
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
migraine	migraine	nn1
,	,	y
but	but	ccb
lower	low	jjr
odds	odds	nn2
of	of	io
lifetime	lifetime	nnt1
arthritis	arthritis	nn1
.	.	y
Regarding	regarding	ii_vvg
infectious	infectious	jj
diseases	disease	nn2
,	,	y
hazardous	hazardous	jj
substance	substance	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
odds	odds	nn2
of	of	io
reporting	report	vvg_jj@_nn1
lifetime	lifetime	nnt1
TB	tb	nn1
,	,	y
and	and	cc
hepatitis	hepatitis	nn1
B.	b	np1
Regarding	regarding	ii_vvg
cardiovascular	cardiovascular	jj
diseases	disease	nn2
,	,	y
hazardous	hazardous	jj
substance	substance	nn1
users	user	nn2
had	have	vhd
lower	low	jjr
odds	odds	nn2
of	of	io
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
hypertension	hypertension	nn1
and	and	cc
heart	heart	nn1
disease	disease	nn1
,	,	y
although	although	cs
there	there	ex
was	be	vbdz
no	no	at
difference	difference	nn1
for	for	if
stroke	stroke	nn1
.	.	y
Hazardous	hazardous	jj
substance	substance	nn1
users	user	nn2
had	have	vhd
higher	high	jjr
odds	odds	nn2
of	of	io
reporting	report	vvg_jj@_nn1
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
liver	liver	nn1
disease	disease	nn1
,	,	y
lifetime	lifetime	nnt1
bladder	bladder	nn1
infection	infection	nn1
,	,	y
and	and	cc
slightly	slightly	rr
higher	high	jjr
odds	odds	nn2
of	of	io
reporting	report	vvg
current	current	jj
cancer	cancer	nn1
.	.	y
On	on	ii
the	the	at
other	other	jj
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
current	current	jj
STDs	std	nn2
and	and	cc
lifetime	lifetime	nnt1
benign	benign	jj
prostate	prostate	nn1
problems	problem	nn2
.	.	y
Hazardous	hazardous	jj
substance	substance	nn1
users	user	nn2
had	have	vhd
lower	low	jjr
lifetime	lifetime	nnt1
but	but	ccb
higher	high	jjr_rrr@
current	current	jj
odds	odds	nn2
of	of	io
anemia	anemia	nn1
.	.	y
To	to	to
further	far	rrr
examine	examine	vvi
the	the	at
negative	negative	jj
relationships	relationship	nn2
of	of	io
reporting	report	vvg
any	any	dd
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
(	(	y
i.e.	ie	rex
,	,	y
any	any	dd
hazardous	hazardous	jj
alcohol	alcohol	nn1
,	,	y
drug	drug	nn1
or	or	cc
tobacco	tobacco	nn1
use	use	nn1
)	)	y
to	to	ii
medical	medical	jj
conditions	condition	nn2
,	,	y
we	we	ppis2
conducted	conduct	vvd
post-hoc	post-hoc	jj_nn1
analyses	analysis	nn2_vvz
as	as	csa
above	above	rl
for	for	if
drinking	drinking	nn1_vvg
.	.	y
We	we	ppis2
re-ran	re-ran	vvd
the	the	at
logistic	logistic	jj
regression	regression	nn1
models	model	nn2
after	after	ii
removing	remove	vvg
those	those	dd2
who	who	pnqs
reported	report	vvd
abstaining	abstain	vvg
from	from	ii
alcohol	alcohol	nn1
in	in	ii_rp@
at	at	rr21
least	least	rr22
the	the	at
past	past	jj
three	three	mc
months	month	nnt2
(	(	y
not	not	xx
shown	show	vvn
)	)	y
.	.	y
In	in	ii
these	these	dd2
models	model	nn2
,	,	y
the	the	at
negative	negative	jj
relationships	relationship	nn2
of	of	io
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
to	to	ii
lifetime	lifetime	nnt1
arthritis	arthritis	nn1
,	,	y
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
hypertension	hypertension	nn1
,	,	y
lifetime	lifetime	nnt1
and	and	cc
current	current	jj
heart	heart	nn1
disease	disease	nn1
were	be	vbdr
no	no	rr21
longer	long	rr22
significant	significant	jj
.	.	y
Also	also	rr
,	,	y
the	the	at
negative	negative	jj
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
to	to	ii
lifetime	lifetime	nnt1
anemia	anemia	nn1
reversed	reverse	vvd_vvn_jj@
direction	direction	nn1
so	so	cs21
that	that	cs22
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
was	be	vbdz
related	relate	vvn
to	to	ii
a	a	at1
higher	high	jjr
likelihood	likelihood	nn1
of	of	io
lifetime	lifetime	nnt1
anemia	anemia	nn1
.	.	y
On	on	ii
the	the	at
other	other	jj
hand	hand	nn1
,	,	y
the	the	at
positive	positive	jj
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
to	to	ii
lifetime	lifetime	nnt1
bladder	bladder	nn1
infections	infection	nn2
was	be	vbdz
no	no	rr21
longer	long	rr22
significant	significant	jj
.	.	y
A	a	at1_zz1
new	new	jj
relationship	relationship	nn1
emerged	emerge	vvd_vvn@
of	of	io
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
to	to	ii
current	current	jj
TB	tb	nn1
(	(	y
OR=1.92		fo
;	;	y
95%	95%	nnu
CIs=1.08		fo
,	,	y
3.42	3.42	mc
)	)	y
.	.	y
The	the	at
relationships	relationship	nn2
of	of	io
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
to	to	ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
lifetime	lifetime	nnt1
Hepatitis	hepatitis	nn1_np1
B	b	zz1_np1@
(	(	y
OR=4.62		fo
;	;	y
p	xx_p	zz1
=	=	fo
.083	.083	mc
)	)	y
,	,	y
lifetime	lifetime	nnt1
cancer	cancer	nn1
(	(	y
OR=2.02		fo
;	;	y
p	xx_p	zz1
=	=	fo
.062	.062	mc
)	)	y
and	and	cc
current	current	jj
cancer	cancer	nn1
(	(	y
OR=2.89		fo
;	;	y
p	xx_p	zz1
=	=	fo
.064	.064	mc
)	)	y
approached	approach	vvd_vvn
significance	significance	nn1
.	.	y
DISCUSSION	discussion	nn1
In	in	ii
this	this	dd1
descriptive	descriptive	jj
study	study	nn1
we	we	ppis2
examined	examine	vvd
the	the	at
odds	odds	nn2
of	of	io
current	current	jj
and	and	cc
lifetime	lifetime	nnt1
medical	medical	jj
problems	problem	nn2
in	in	ii
those	those	dd2
with	with	iw
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
(	(	y
i.e.	ie	rex
,	,	y
hazardous	hazardous	jj
alcohol	alcohol	nn1
use	use	nn1
or	or	cc
hazardous	hazardous	jj
use	use	nn1
of	of	io
other	other	jj
drugs	drug	nn2
or	or	cc
tobacco	tobacco	nn1
)	)	y
compared	compare	vvn_vvd@
to	to	ii
those	those	dd2
who	who	pnqs
did	do	vdd
not	not	xx
have	have	vhi
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
.	.	y
We	we	ppis2
found	find	vvd
heightened	heightened	jj
odds	odds	nn2
of	of	io
many	many	da2
medical	medical	jj
disorders	disorder	nn2
for	for	if
those	those	dd2
with	with	iw
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
in	in	ii
this	this	dd1
primary	primary	jj_nn1
care	care	nn1
,	,	y
economically	economically	rr
disadvantaged	disadvantaged	jj
population	population	nn1
,	,	y
notably	notably	rr
infectious	infectious	jj
diseases	disease	nn2
such	such	ii21
as	as	ii22
TB	tb	nn1
and	and	cc
Hepatitis	hepatitis	np1_nn1
B	b	zz1_np1@
and	and	cc
C.	c	np1_zz1@
The	the	at
heightened	heightened	jj
risk	risk	nn1
of	of	io
these	these	dd2
conditions	condition	nn2
in	in	ii
hazardous	hazardous	jj
substance	substance	nn1
users	user	nn2
(	(	y
particularly	particularly	rr
TB	tb	nn1
,	,	y
a	a	at1
highly	highly	rr
prevalent	prevalent	jj
condition	condition	nn1
in	in	ii
South	south	np1
Africa	africa	np1
)	)	y
warrants	warrant	vvz
attention	attention	nn1
to	to	ii
screening	screen	vvg_nn1
for	for	if
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
as	as	ii_csa
a	a	at1
potential	potential	jj_nn1
risk	risk	nn1
factor	factor	nn1
.	.	y
Hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
drug	drug	nn1
use	use	nn1_vv0
,	,	y
and	and	cc
tobacco	tobacco	nn1
use	use	nn1
were	be	vbdr
each	each	dd1
related	relate	vvd_vvn_jj
to	to	ii
a	a	at1
heightened	heightened	jj
risk	risk	nn1
for	for	if
TB	tb	nn1
.	.	y
This	this	dd1
is	be	vbz
consistent	consistent	jj
with	with	iw
research	research	nn1
showing	show	vvg
a	a	at1
decreased	decreased	jj@
immune	immune	jj
function	function	nn1
in	in	ii
those	those	dd2
with	with	iw
alcohol	alcohol	nn1
disorders	disorder	nn2
(	(	y
National	national	jj
Institute	institute	nn1
on	on	ii
Alcohol	alcohol	nn1
Abuse	abuse	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
an	a	at1
indicator	indicator	nn1
of	of	io
HIV/AIDS	hiv/aids	fu
to	to	ii
which	which	ddq
it	it	pph1
is	be	vbz
highly	highly	rr
related	relate	vvn_vvd
in	in	ii
South	south	np1
Africa	africa	np1
(	(	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
,	,	y
2005	2005	mc
)	)	y
.	.	y
Hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
is	be	vbz
also	also	rr
associated	associate	vvn
with	with	iw
HIV	hiv	np1
risk	risk	nn1_vv0
behaviors	behavior	nn2
in	in	ii
this	this	dd1
sample	sample	nn1
(	(	y
Ward	ward	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
.	.	y
The	the	at
higher	high	jjr
prevalence	prevalence	nn1
of	of	io
TB	tb	nn1
in	in	ii
hazardous	hazardous	jj
drinkers	drinker	nn2
and	and	cc
hazardous	hazardous	jj
drug	drug	nn1
users	user	nn2
versus	versus	ii
others	others	nn2
in	in	ii
primary	primary	jj_nn1
care	care	nn1
has	have	vhz
important	important	jj
cost	cost	nn1
implications	implication	nn2
,	,	y
since	since	cs
the	the	at
costs	cost	nn2
of	of	io
diagnosis	diagnosis	nn1
and	and	cc
treatment	treatment	nn1
of	of	io
TB	tb	nn1
are	be	vbr
very	very	rg
high	high	jj_rr@
in	in	ii
South	south	np1
Africa	africa	np1
(	(	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
,	,	y
2005	2005	mc
)	)	y
.	.	y
Hepatitis	hepatitis	nn1_np1@
A	a	zz1
and	and	cc
B	b	zz1
are	be	vbr
also	also	rr
infectious	infectious	jj
diseases	disease	nn2
which	which	ddq
have	have	vh0
much	much	rr_da1
higher	high	jjr
prevalence	prevalence	nn1
in	in	ii
developing	developing	jj_vvg
than	than	csn
developed	developed	jj
countries	country	nn2
(	(	y
Centers	center	nn2
for	for	if
Disease	disease	nn1
Control	control	nn1
and	and	cc
Prevention	prevention	nn1
,	,	y
2007a	2007a	fo
;	;	y
Centers	center	nn2
for	for	if
Disease	disease	nn1
Control	control	nn1
and	and	cc
Prevention	prevention	nn1
,	,	y
2007b	2007b	fo
)	)	y
.	.	y
This	this	dd1
study	study	nn1
found	find	vvd_vvn
unexpected	unexpected	jj
associations	association	nn2
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
and	and	cc
hazardous	hazardous	jj
drug	drug	nn1
use	use	nn1_vv0
to	to	ii
both	both	db2
Hepatitis	hepatitis	np1_nn1
A	a	zz1
and	and	cc
Hepatitis	hepatitis	np1_nn1
B	b	zz1_np1@
in	in	ii
the	the	at
South	south	np1
African	african	jj
primary	primary	jj_nn1
care	care	nn1_vv0
patient	patient	nn1_jj
sample	sample	nn1
.	.	y
These	these	dd2
findings	finding	nn2
may	may	vm
reflect	reflect	vvi
the	the	at
known	known	jj@
effects	effect	nn2
of	of	io
alcohol	alcohol	nn1
misuse	misuse	nn1
on	on	ii
immune	immune	jj
function	function	nn1
(	(	y
National	national	jj
Institute	institute	nn1
on	on	ii
Alcohol	alcohol	nn1
Abuse	abuse	nn1
and	and	cc
Alcoholism	alcoholism	nn1
,	,	y
2000	2000	mc
)	)	y
.	.	y
They	they	pphs2
may	may	vm
also	also	rr
reflect	reflect	vvi
an	a	at1
association	association	nn1
with	with	iw
HIV/AIDs	hiv/aids	fu
,	,	y
particularly	particularly	rr
for	for	if
Hepatitis	hepatitis	np1
B.	b	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
poor	poor	jj
sanitary	sanitary	jj
conditions	condition	nn2
.	.	y
More	more	dar_rrr
research	research	nn1
into	into	ii
the	the	at
causal	causal	jj
mechanisms	mechanism	nn2
of	of	io
the	the	at
association	association	nn1
in	in	ii
this	this	dd1
population	population	nn1
is	be	vbz
warranted	warrant	vvn
.	.	y
The	the	at
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
to	to	ii
Hepatitis	hepatitis	np1_nn1
B	b	zz1_np1@
,	,	y
which	which	ddq
can	can	vm
be	be	vbi
transmitted	transmit	vvn
sexually	sexually	rr
,	,	y
may	may	vm
also	also	rr
indicate	indicate	vvi
that	that	dd1_cst
risky	risky	jj
sexual	sexual	jj
behaviors	behavior	nn2
are	be	vbr
increased	increase	vvn
in	in	ii
patients	patient	nn2
with	with	iw
these	these	dd2
substance	substance	nn1
use	use	nn1_vv0
problems	problem	nn2
.	.	y
We	we	ppis2
know	know	vv0
of	of	io
no	no	at
other	other	jj
studies	study	nn2
that	that	cst
have	have	vh0
examined	examine	vvn
medical	medical	jj
conditions	condition	nn2
related	relate	vvn_vvd
to	to	ii
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
in	in	ii
a	a	at1
population	population	nn1
from	from	ii
a	a	at1
developing	developing	jj
country	country	nn1
.	.	y
However	however	rr
,	,	y
some	some	dd
findings	finding	nn2
are	be	vbr
consistent	consistent	jj
with	with	iw
research	research	nn1
in	in	ii
developed	developed	jj
countries	country	nn2
.	.	y
For	for	rex21
example	example	rex22
,	,	y
hazardous	hazardous	jj
drinking	drinking	nn1
and	and	cc
drug	drug	nn1
use	use	nn1
were	be	vbdr
both	both	rr_db2
related	relate	vvn_vvd
to	to	ii
increased	increased	jj
odds	odds	nn2
for	for	if
current	current	jj
liver	liver	nn1
disease	disease	nn1
.	.	y
Depression	depression	nn1
and	and	cc
anxiety	anxiety	nn1
were	be	vbdr
related	relate	vvn
to	to	ii
hazardous	hazardous	jj
drug	drug	nn1
use	use	nn1_vv0
,	,	y
consistent	consistent	jj
with	with	iw
prior	prior	jj
studies	study	nn2
of	of	io
those	those	dd2
with	with	iw
substance	substance	nn1
use	use	nn1_vv0
problems	problem	nn2
(	(	y
Mertens	mertens	np1
et	et	ra21
al.	al	ra22
,	,	y
2003	2003	mc
)	)	y
,	,	y
but	but	ccb
in	in	ii
contrast	contrast	nn1
to	to	ii
studies	study	nn2
in	in	ii
other	other	jj
populations	population	nn2
(	(	y
Mertens	mertens	np1
et	et	ra21
al.	al	ra22
,	,	y
2005	2005	mc
)	)	y
,	,	y
it	it	pph1
was	be	vbdz
not	not	xx
linked	link	vvn
to	to	ii
hazardous	hazardous	jj
drinking	drinking	nn1
(	(	y
even	even	cs21
when	when	cs22
controlling	control	vvg
for	for	if
social	social	jj
class	class	nn1
)	)	y
.	.	y
Hazardous	hazardous	jj
tobacco	tobacco	nn1
use	use	nn1
was	be	vbdz
also	also	rr
related	relate	vvn_vvd
to	to	ii
a	a	at1
higher	high	jjr
risk	risk	nn1
of	of	io
TB	tb	nn1
as	as	ii31
well	well	ii32
as	as	ii33
other	other	jj
disorders	disorder	nn2
including	including	ii
migraine	migraine	nn1
,	,	y
asthma	asthma	nn1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
other	other	ii21
than	than	ii22
alcohol	alcohol	nn1
and	and	cc
tobacco	tobacco	nn1
was	be	vbdz
related	relate	vvn
to	to	ii
a	a	at1
higher	high	jjr
risk	risk	nn1
of	of	io
many	many	da2
disorders	disorder	nn2
including	including	ii
migraine	migraine	nn1
,	,	y
TB	tb	nn1
,	,	y
COPD	copd	nn1
,	,	y
Depression/Anxiety	depression/anxiety	nn1
,	,	y
Hepatitis	hepatitis	np1_nn1
A	a	zz1
and	and	cc
B	b	zz1
,	,	y
bladder	bladder	nn1
infection	infection	nn1
,	,	y
and	and	cc
stomach	stomach	nn1
ulcers	ulcer	nn2
.	.	y
Interestingly	interestingly	rr
,	,	y
hazardous	hazardous	jj
drug	drug	nn1
use	use	nn1_vv0
,	,	y
unlike	unlike	jj_ii@
hazardous	hazardous	jj
drinking	drinking	nn1
,	,	y
was	be	vbdz
not	not	xx
related	relate	vvn
to	to	ii
STDs	std	nn2
.	.	y
Hazardous	hazardous	jj
drinking	drinking	nn1
was	be	vbdz
related	relate	vvn
to	to	ii
a	a	at1
higher	high	jjr
risk	risk	nn1
of	of	io
lifetime	lifetime	nnt1
TB	tb	nn1
and	and	cc
current	current	jj
STDs	std	nn2
,	,	y
but	but	ccb
to	to	ii
few	few	da2
other	other	jj
disorders	disorder	nn2
,	,	y
particularly	particularly	rr
after	after	ii
controlling	control	vvg
for	for	if
abstinence	abstinence	nn1
.	.	y
Removing	remove	vvg
abstainers	abstainer	nn2
from	from	ii
the	the	at
reference	reference	nn1
group	group	nn1
reduced	reduce	vvd_vvn
the	the	at
association	association	nn1
between	between	ii
hazardous	hazardous	jj
drinking	drinking	nn1
and	and	cc
a	a	at1
higher	high	jjr
risk	risk	nn1
of	of	io
liver	liver	nn1
cirrhosis	cirrhosis	nn1
.	.	y
This	this	dd1
is	be	vbz
most	most	rgt
likely	likely	jj
because	because	cs
lifetime	lifetime	nnt1
abstainers	abstainer	nn2
,	,	y
who	who	pnqs
made	make	vvd
up	up	rp
the	the	at
majority	majority	nn1
of	of	io
the	the	at
abstainers	abstainer	nn2
,	,	y
are	be	vbr
not	not	xx
exposed	expose	vvn
to	to	ii
alcohol	alcohol	nn1
,	,	y
which	which	ddq
is	be	vbz
a	a	at1
primary	primary	jj_nn1
cause	cause	nn1
of	of	io
cirrhosis	cirrhosis	nn1
.	.	y
A	a	at1_zz1
similar	similar	jj
reduction	reduction	nn1
in	in	ii
the	the	at
odds	odds	nn2
ratio	ratio	nn1
examining	examine	vvg
the	the	at
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
COPD	copd	nn1
occurs	occur	vvz
when	when	cs
removing	remove	vvg
abstainers	abstainer	nn2
from	from	ii
the	the	at
reference	reference	nn1
group	group	nn1
,	,	y
perhaps	perhaps	rr
because	because	cs
there	there	ex
is	be	vbz
a	a	at1
very	very	rg
low	low	jj
prevalence	prevalence	nn1
of	of	io
smoking	smoke	vvg_nn1_jj
in	in	ii
lifetime	lifetime	nnt1
abstainers	abstainer	nn2
,	,	y
and	and	cc
smoking	smoking	nn1_vvg
is	be	vbz
a	a	at1
primary	primary	jj_nn1
contributing	contributing	jj@_vvg
factor	factor	nn1
to	to	ii
COPD	copd	nn1
.	.	y
Our	our	appge
initial	initial	jj_nn1
analyses	analysis	nn2
found	find	vvd_vvn
a	a	at1
lower	low	jjr
risk	risk	nn1
of	of	io
some	some	dd
medical	medical	jj
conditions	condition	nn2
,	,	y
such	such	ii21
as	as	ii22
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
.	.	y
The	the	at
relationships	relationship	nn2
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
heart	heart	nn1
disease	disease	nn1
and	and	cc
stroke	stroke	nn1_vv0
remained	remain	vvd_vvn
even	even	cs21
when	when	cs22
controlling	control	vvg
for	for	if
abstinence	abstinence	nn1
status	status	nn1
.	.	y
This	this	dd1
is	be	vbz
consistent	consistent	jj
with	with	iw
prior	prior	jj
studies	study	nn2
which	which	ddq
have	have	vh0
found	find	vvn
a	a	at1
lower	low	jjr
risk	risk	nn1
of	of	io
death	death	nn1
from	from	ii
cardiovascular	cardiovascular	jj
diseases	disease	nn2
among	among	ii
lighter	light	jjr_nn1
drinkers	drinker	nn2
(	(	y
i.e.	ie	rex
,	,	y
1-2	1-2	mcmc
drinks	drink	nn2
per	per	ii
day	day	nnt1
)	)	y
but	but	ccb
a	a	at1
higher	high	jjr
risk	risk	nn1
of	of	io
death	death	nn1
from	from	ii
trauma	trauma	nn1
,	,	y
cirrhosis	cirrhosis	nn1
and	and	cc
all	all	db_rr@
non-cardiovascular	non-cardiovascular	jj
causes	cause	nn2
in	in	ii
heavy	heavy	jj
drinkers	drinker	nn2
(	(	y
i.e.	ie	rex
,	,	y
6	6	mc
or	or	cc
more	more	dar
drinks	drink	nn2
per	per	ii
day	day	nnt1
)	)	y
(	(	y
Klatsky	klatsky	np1
,	,	y
Armstron	armstron	np1_nn1
,	,	y
&;		null
Freidman	freidman	np1_nn1
,	,	y
1992	1992	mc
)	)	y
.	.	y
On	on	ii
the	the	at
other	other	jj
hand	hand	nn1
,	,	y
perhaps	perhaps	rr
because	because	cs
lifetime	lifetime	nnt1
abstainers	abstainer	nn2
have	have	vh0
no	no	at
exposure	exposure	nn1
to	to	ii
alcohol	alcohol	nn1
which	which	ddq
can	can	vm
increase	increase	vvi
high	high	jj
blood	blood	nn1
pressure	pressure	nn1
,	,	y
the	the	at
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
a	a	at1
lower	low	jjr
risk	risk	nn1
of	of	io
hypertension	hypertension	nn1
diminished	diminish	vvn_vvd
and	and	cc
lost	lost	jj@_vvd_vvn
significance	significance	nn1
when	when	cs
removing	remove	vvg
abstainers	abstainer	nn2
from	from	ii
the	the	at
reference	reference	nn1
group	group	nn1
.	.	y
Our	our	appge
focus	focus	nn1
here	here	rl
was	be	vbdz
to	to	to
mainly	mainly	rr
describe	describe	vvi
the	the	at
increased	increased	jj
risk	risk	nn1
of	of	io
medical	medical	jj
conditions	condition	nn2
for	for	if
hazardous	hazardous	jj
drinkers	drinker	nn2
in	in	ii
a	a	at1
clinical	clinical	jj
setting	setting	nn1
,	,	y
and	and	cc
we	we	ppis2
have	have	vh0
very	very	rg
limited	limit	vvn
data	data	nn
on	on	ii
quantity	quantity	nn1
and	and	cc
frequency	frequency	nn1
of	of	io
alcohol	alcohol	nn1
consumption	consumption	nn1
in	in	ii
this	this	dd1
cross-sectional	cross-sectional	jj
study	study	nn1
.	.	y
However	however	rr
,	,	y
future	future	jj
prospective	prospective	jj
research	research	nn1
should	should	vm
examine	examine	vvi
the	the	at
relationship	relationship	nn1
of	of	io
consumption	consumption	nn1
patterns	pattern	nn2
to	to	ii
medical	medical	jj
conditions	condition	nn2
in	in	ii
developing	developing	jj_vvg
country	country	nn1
populations	population	nn2
.	.	y
The	the	at
current	current	jj
study	study	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
medical	medical	jj
conditions	condition	nn2
and	and	cc
substance	substance	nn1
use	use	nn1
.	.	y
However	however	rr
,	,	y
there	there	ex
are	be	vbr
no	no	at
systematic	systematic	jj
data	data	nn
available	available	jj
on	on	ii
clinical	clinical	jj
diagnoses	diagnosis	nn2
of	of	io
medical	medical	jj
problems	problem	nn2
in	in	ii
this	this	dd1
population	population	nn1
.	.	y
A	a	at1
second	second	md_nnt1
limitation	limitation	nn1
is	be	vbz
the	the	at
relatively	relatively	rr
high	high	jj
rate	rate	nn1
of	of	io
those	those	dd2
who	who	pnqs
were	be	vbdr
sampled	sample	vvn
but	but	ccb
not	not	xx
recruited	recruit	vvn
.	.	y
However	however	rr
,	,	y
for	for	if
the	the	at
current	current	jj
study	study	nn1
,	,	y
we	we	ppis2
focused	focus	vvd
more	more	rrr_dar
on	on	ii
relative	relative	jj_nn1
risk	risk	nn1
than	than	csn
absolute	absolute	jj
risk	risk	nn1
.	.	y
While	while	cs
the	the	at
prevalence	prevalence	nn1
may	may	vm
differ	differ	vvi
among	among	ii
those	those	dd2
not	not	xx
recruited	recruit	vvn
,	,	y
there	there	ex
is	be	vbz
no	no	at
reason	reason	nn1
to	to	to
expect	expect	vvi
bias	bias	nn1
in	in	ii
the	the	at
relationship	relationship	nn1
of	of	io
substance	substance	nn1
use	use	nn1_vv0
to	to	ii
medical	medical	jj
problems	problem	nn2
in	in	ii
those	those	dd2
recruited	recruit	vvn
.	.	y
Further	far	rrr_jjr
,	,	y
our	our	appge
results	result	nn2
were	be	vbdr
generally	generally	rr
consistent	consistent	jj
with	with	iw
research	research	nn1
on	on	ii
these	these	dd2
issues	issue	nn2
in	in	ii
other	other	jj
populations	population	nn2
,	,	y
lending	lend	vvg_nn1
support	support	nn1_vv0
for	for	if
our	our	appge
findings	finding	nn2
.	.	y
Where	where	rrq_cs
differences	difference	nn2
from	from	ii
prior	prior	jj
research	research	nn1
were	be	vbdr
found	find	vvn
,	,	y
for	for	rex21
example	example	rex22
the	the	at
relationship	relationship	nn1
of	of	io
hazardous	hazardous	jj
drinking	drinking	nn1
to	to	ii
a	a	at1
lower	low	jjr
risk	risk	nn1
of	of	io
depression/anxiety	depression/anxiety	nn1
in	in	ii
our	our	appge
sample	sample	nn1
,	,	y
these	these	dd2
relationships	relationship	nn2
should	should	vm
be	be	vbi
further	far	rrr
investigated	investigate	vvn
by	by	ii
prospective	prospective	jj
research	research	nn1
.	.	y
A	a	at1
third	third	md
limitation	limitation	nn1
is	be	vbz
that	that	cst_dd1
,	,	y
due	due	ii21
to	to	ii22
confidentiality	confidentiality	nn1
concerns	concern	nn2_vvz
and	and	cc
low	low	jj
availability	availability	nn1
and	and	cc
a	a	at1
low	low	jj
rate	rate	nn1
of	of	io
HIV/AIDS	hiv/aids	fu
testing	testing	nn1
in	in	ii
this	this	dd1
population	population	nn1
during	during	ii
the	the	at
time	time	nnt1
of	of	io
the	the	at
study	study	nn1
(	(	y
so	so	cs21
that	that	cs22
HIV	hiv	np1
status	status	nn1
is	be	vbz
often	often	rr
unknown	unknown	jj
)	)	y
,	,	y
we	we	ppis2
did	do	vdd
not	not	xx
ask	ask	vvi
about	about	ii
HIV/	hiv/	fu
AIDS	aids	nn1_nn2@
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
condition	condition	nn1
.	.	y
Future	future	jj
prospective	prospective	jj
research	research	nn1
should	should	vm
document	document	vvi
the	the	at
association	association	nn1
of	of	io
hazardous	hazardous	jj
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
to	to	ii
HIV	hiv	np1
test	test	nn1_vv0
results	result	nn2_vvz@
in	in	ii
a	a	at1
study	study	nn1
in	in	ii
which	which	ddq
both	both	db2_rr
substance	substance	nn1
use	use	nn1_vv0
treatment	treatment	nn1
and	and	cc
HIV/AIDS	hiv/aids	fu
treatment	treatment	nn1
(	(	y
and	and	cc
,	,	y
ideally	ideally	rr
,	,	y
mental	mental	jj
health	health	nn1
services	service	nn2
as	as	rr21_rg
well	well	rr22_rr
)	)	y
are	be	vbr
easily	easily	rr
accessible	accessible	jj
to	to	to
study	study	vvi
participants	participant	nn2
.	.	y
A	a	at1_zz1
final	final	jj
limitation	limitation	nn1
is	be	vbz
that	that	cst
our	our	appge
data	data	nn
are	be	vbr
cross-sectional	cross-sectional	jj
and	and	cc
we	we	ppis2
are	be	vbr
unable	unable	jk
to	to	to
determine	determine	vvi
causality	causality	nn1
or	or	cc
whether	whether	csw
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1
began	begin	vvd
before	before	ii_rt@_cs
or	or	cc
after	after	cs_ii
these	these	dd2
medical	medical	jj
conditions	condition	nn2
developed	develop	vvn_vvd
.	.	y
However	however	rr
,	,	y
this	this	dd1
is	be	vbz
the	the	at
first	first	md
study	study	nn1
that	that	cst
we	we	ppis2
know	know	vv0
of	of	io
to	to	to
examine	examine	vvi
these	these	dd2
relationships	relationship	nn2
in	in	ii
this	this	dd1
population	population	nn1
.	.	y
Future	future	jj_nn1
research	research	nn1
should	should	vm
investigate	investigate	vvi
this	this	dd1
issue	issue	nn1
prospectively	prospectively	rr
,	,	y
particularly	particularly	rr
for	for	if
hazardous	hazardous	jj
drinking	drinking	nn1
.	.	y
CONCLUSIONS	conclusion	nn2
Our	our	appge
findings	finding	nn2
suggest	suggest	vv0
that	that	dd1_cst
treatment	treatment	nn1
for	for	if
some	some	dd
medical	medical	jj
conditions	condition	nn2
may	may	vm
benefit	benefit	vvi
from	from	ii
identification	identification	nn1
and	and	cc
treatment	treatment	nn1
of	of	io
associated	associated	jj
hazardous	hazardous	jj
substance	substance	nn1
use	use	nn1_vv0
,	,	y
particularly	particularly	rr
use	use	nn1_vv0
of	of	io
drugs	drug	nn2
other	other	ii21
than	than	ii22
alcohol	alcohol	nn1
.	.	y
Access	access	nn1_vv0@
to	to	ii
substance	substance	nn1
use	use	nn1_vv0
treatment	treatment	nn1
is	be	vbz
limited	limit	vvn
in	in	ii
these	these	dd2
populations	population	nn2
and	and	cc
offering	offer	vvg_nn1
even	even	rr
brief	brief	jj
interventions	intervention	nn2
or	or	cc
advice	advice	nn1
for	for	if
substance	substance	nn1
use	use	nn1
may	may	vm
be	be	vbi
useful	useful	jj
.	.	y
Future	future	jj_nn1
research	research	nn1
should	should	vm
examine	examine	vvi
the	the	at
prospective	prospective	jj
relationship	relationship	nn1
of	of	io
substance	substance	nn1
use	use	nn1_vv0
,	,	y
and	and	cc
alcohol	alcohol	nn1
consumption	consumption	nn1
in	in	rr21
particular	particular	rr22
,	,	y
to	to	ii
medical	medical	jj
conditions	condition	nn2
in	in	ii
primary	primary	jj_nn1
care	care	nn1
populations	population	nn2
in	in	ii
developing	developing	jj_vvg
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
Bruce	bruce	np1
Fireman	fireman	np1
,	,	y
M.A.	m.a	nna
for	for	cs%
statistical	statistical	jj
support	support	nn1
,	,	y
and	and	cc
the	the	at
field	field	nn1
workers	worker	nn2
,	,	y
Beulah	beulah	np1
Marks	marks	np1
,	,	y
Bongu		np1
Maku	maku	np1_nn1
,	,	y
Morris	morris	np1
Manuel	manuel	np1
,	,	y
and	and	cc
Asanda		np1
Mabusela		np1
.	.	y
We	we	ppis2
are	be	vbr
also	also	rr
grateful	grateful	jj
to	to	ii
the	the	at
patients	patient	nn2
who	who	pnqs
participated	participate	vvd
in	in	ii_rp@
this	this	dd1
study	study	nn1
.	.	y
The	the	at
U.S.	us	np1
National	national	jj
Institute	institute	nn1
on	on	ii
Drug	drug	nn1
Abuse	abuse	nn1
(	(	y
through	through	ii
the	the	at
Southern	southern	jj
Africa	africa	np1
Initiative	initiative	nn1
)	)	y
and	and	cc
the	the	at
South	south	np1
African	african	jj
Medical	medical	jj
Research	research	nn1
Council	council	nn1
provided	provided	cs_vvd_vvn
study	study	nn1
funding	funding	nn1
.	.	y
Table	table	nn1_vv0%
1	1	mc1
:	:	y
Demographic	demographic	jj
Characteristics	characteristic	nn2
of	of	io
Sample	sample	nn1
(	(	y
weighted	weighted	jj_vvn
)	)	y
(	(	y
*	*	fu
)	)	y
pre-formatted	pre-formatted	zz
table	table	nn1
REFERENCES	reference	vvz@_nn2
Ashton	ashton	np1
,	,	y
C.	c	np1
H.	h	np1
2001	2001	mc
Pharmacology	pharmacology	np1_nn1
and	and	cc
effects	effect	nn2
of	of	io
cannabis	cannabis	nn1
:	:	y
A	a	zz1_at1@
brief	brief	jj
review	review	nn1
.	.	y
British	british	jj
Journal	journal	nn1
of	of	io
Psychiatry	psychiatry	np1_nn1
,	,	y
178	178	mc
,	,	y
101-106		mcmc
.	.	y
Babor	babor	nn1_np1@
,	,	y
T.	t	np1
F.	f	np1
,	,	y
&;		null
Higgins-Biddle		np1
,	,	y
J.	xx_j	np1
C	c	np1_zz1
2001	2001	mc
Brief	brief	jj
intervention	intervention	nn1
for	for	if
hazardous	hazardous	jj
and	and	cc
harmful	harmful	jj
drinking	drinking	nn1
:	:	y
A	a	zz1_at1@
manual	manual	jj_nn1
for	for	if
use	use	nn1
in	in	ii
primary	primary	jj_nn1
care	care	nn1
.	.	y
Geneva	geneva	np1
:	:	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
.	.	y
Babor	babor	nn1_np1@
,	,	y
T.	t	np1
F.	f	np1
,	,	y
Higgins-Biddle		np1
,	,	y
J.	xx_j	np1
C.	c	np1
,	,	y
Saunders	saunders	np1
,	,	y
J.	xx_j	np1
B.	b	np1
,	,	y
&;		null
Monteiro	monteiro	np1
,	,	y
M.	m	nn1_nnu@
G.	g	np1_nnu@
2001	2001	mc
AUDIT	audit	nn1
.	.	y
The	the	at
alcohol	alcohol	nn1
use	use	nn1_vv0
disorders	disorder	nn2
identification	identification	nn1
test	test	nn1
.	.	y
Guidelines	guideline	nn2
for	for	if
use	use	nn1
in	in	ii
primary	primary	jj_nn1
care	care	nn1
.	.	y
Geneva	geneva	np1
:	:	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
,	,	y
Department	department	nn1
of	of	io
Mental	mental	jj
Health	health	nn1
and	and	cc
Substance	substance	nn1
Dependence	dependence	nn1
.	.	y
Centers	center	nn2
for	for	if
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
specific	specific	jj
infectious	infectious	jj
diseases	disease	nn2
.	.	y
Hepatitis	hepatitis	nn1_np1@
,	,	y
viral	viral	jj
,	,	y
Type	type	nn1
A.		zz
In	in	ii
Travelers	traveler	np1
'	'	ge
health	health	nn1
:	:	y
Yellow	yellow	jj
book	book	nn1
.	.	y
Health	health	nn1
information	information	nn1
for	for	if
international	international	jj
travel	travel	nn1
,	,	y
2005-2006	2005-2006	mcmc
.	.	y
Atlanta	atlanta	np1
,	,	y
GA	ga	np1
.	.	y
Centers	center	nn2
for	for	if
Disease	disease	nn1
Control	control	nn1
and	and	cc
Prevention	prevention	nn1
.	.	y
2007	2007	mc
Chapter	chapter	nn1
4	4	mc
-	-	-
Prevention	prevention	nn1
of	of	io
specific	specific	jj
infectious	infectious	jj
diseases	disease	nn2
.	.	y
Hepatitis	hepatitis	nn1_np1@
,	,	y
viral	viral	jj
,	,	y
Type	type	nn1
B.	b	np1
In	in	ii
travelers	traveler	nn2
'	'	ge
health	health	nn1
:	:	y
Yellow	yellow	jj
book	book	nn1
.	.	y
Health	health	nn1
information	information	nn1
for	for	if
international	international	jj
travel	travel	nn1
,	,	y
2005-2006	2005-2006	mcmc
.	.	y
Atlanta	atlanta	np1
,	,	y
GA	ga	np1
.	.	y
Chou	chou	np1
,	,	y
S.	s	zz
P.	xx_p	np1
,	,	y
Grant	grant	np1
,	,	y
B.	b	np1
F.	f	np1
,	,	y
&;		null
Dawson	dawson	np1
,	,	y
D.	d	np1
A.	a	zz
1996	1996	mc
Medical	medical	jj
consequences	consequence	nn2
of	of	io
alcohol	alcohol	nn1
consumption	consumption	nn1
--		nn1_jj
United	united	np1
States	state	np1
,	,	y
1992	1992	mc
.	.	y
Alcoholism	alcoholism	nn1
:	:	y
Clinical	clinical	jj
and	and	cc
Experimental	experimental	jj
Research	research	nn1
,	,	y
20(8)		fo
,	,	y
1423-1429		mcmc
.	.	y
Dufour	dufour	vv0_nn1_np1@
,	,	y
M.	m	nn1
C.	c	np1_zz1@
,	,	y
&;		null
Fe	fe	np1
Caces	caces	np2
,	,	y
M.	m	nn1
1993	1993	mc
Epidemiology	epidemiology	nn1
of	of	io
the	the	at
medical	medical	jj
consequences	consequence	nn2
of	of	io
alcohol	alcohol	nn1
.	.	y
Alcohol	alcohol	nn1
Health	health	nn1
and	and	cc
Research	research	nn1_vv0@
World	world	nn1
,	,	y
17(4)	17(4)	fo
,	,	y
265-271		mcmc
.	.	y
Edmunds	edmunds	np1
,	,	y
M.	m	nn1
,	,	y
Frank	frank	np1
,	,	y
R.	xx_r	np1
,	,	y
Hogan	hogan	np1
,	,	y
M.	m	nn1
,	,	y
McCarty	mccarty	np1
,	,	y
D.	d	np1
,	,	y
Robinson-Beale		np1
,	,	y
R.	xx_r	np1
,	,	y
Weisner	weisner	np1_nn1
,	,	y
C.	c	np1_zz1@
,	,	y
&;		null
Committee	committee	nn1
on	on	ii
Quality	quality	nn1
Assurance	assurance	nn1
and	and	cc
Accreditation	accreditation	nn1
Guidelines	guideline	nn2
for	for	if
Managed	manage	vvn
Behavioral	behavioral	jj
Health	health	nn1
Care	care	nn1
(	(	y
Eds.	eds	nn2
)	)	y
.	.	y
1997	1997	mc
Managing	managing	nn1_jj
managed	manage	vvd_vvn_jj%
care	care	nn1
:	:	y
Quality	quality	nn1
improvement	improvement	nn1
in	in	ii
behavioral	behavioral	jj_nn1
health	health	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
G.	g	np1
,	,	y
&;		null
Peters	peters	np
,	,	y
T.	t	np1
J.	xx_j	np1
1996	1996	mc
Conclusions	conclusion	nn2
.	.	y
In	in	ii
T.	t	np1
J.	xx_j	np1
Peters	peter	vvz@
(	(	y
Ed	ed	np1
.	.	y
)	)	y
,	,	y
Alcohol	alcohol	nn1
misuse	misuse	nn1
:	:	y
A	a	zz1_at1@
European	european	jj
perspective	perspective	nn1
(	(	y
pp.	pp	nnu2
195-197		mcmc
)	)	y
.	.	y
Amsterdam	amsterdam	np1
:	:	y
Harwood	harwood	np1
Academic	academic	jj
Publisher	publisher	nn1
.	.	y
Fleming	fleming	np1
,	,	y
M.	m	nnu@_nn1
F.	f	ra@_np1
,	,	y
Mundt	mundt	np1
,	,	y
M.	m	nn1
P.	xx_p	np1_nn1@
,	,	y
French	french	nn1_jj_np1@
,	,	y
M.	m	nn1
T.	t	np1
,	,	y
Manwell	manwell	np1
,	,	y
L.	l	zz
B.	b	np1
,	,	y
Stauffacher	stauffacher	np1_nn1
,	,	y
E.	e	np1
A.	a	zz
,	,	y
&;		null
Barry	barry	np1
,	,	y
K.	k	np1
L.	l	zz
2002	2002	mc
Brief	brief	jj
physician	physician	nn1
advice	advice	nn1
for	for	if
problem	problem	nn1
drinkers	drinker	nn2
:	:	y
Long-term	long-term	jj
efficacy	efficacy	nn1
and	and	cc
benefit-cost	benefit-cost	jj_vv0_nn1
analysis	analysis	nn1
.	.	y
Alcoholism	alcoholism	nn1
:	:	y
Clinical	clinical	jj
and	and	cc
Experimental	experimental	jj
Research	research	nn1
,	,	y
26(1)	26(1)	fo
,	,	y
36-43	36-43	mcmc
.	.	y
Gmel	gmel	vv0_nn1_np1@
,	,	y
G.	g	np1
,	,	y
&;		null
Rehm	rehm	np1_nn1
,	,	y
J.	xx_j	np1
2003	2003	mc
Harmful	harmful	jj
alcohol	alcohol	nn1
use	use	nn1
.	.	y
Alcohol	alcohol	nn1
Research	research	nn1
and	and	cc
Health	health	nn1
,	,	y
27(1)	27(1)	fo
,	,	y
52-62	52-62	mcmc
.	.	y
Grant	grant	np1_vv0
,	,	y
B.	b	np1
F.	f	np1
,	,	y
&;		null
Dawson	dawson	np1
,	,	y
D.	d	np1
A.	a	zz
1999	1999	mc
Alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
use	use	nn1_vv0
,	,	y
abuse	abuse	nn1_vv0@
,	,	y
and	and	cc
dependence	dependence	nn1
:	:	y
Classification	classification	nn1
,	,	y
prevalence	prevalence	nn1
,	,	y
and	and	cc
comorbidity	comorbidity	nn1
.	.	y
In	in	ii
B.	b	np1
S.	s	zz
McCrady	mccrady	np1
,	,	y
&;		null
E.	e	np1
E.	e	np1
Epstein	epstein	np1
(	(	y
Eds	ed	nn2
.	.	y
)	)	y
,	,	y
Addictions	addiction	nn2
:	:	y
A	a	zz1_at1@
comprehensive	comprehensive	jj
guidebook	guidebook	nn1
(	(	y
pp.	pp	nnu2
9-29	9-29	mcmc
)	)	y
.	.	y
New	new	np1
York	york	np1
:	:	y
Oxford	oxford	np1
University	university	nn1
Press	press	nn1
.	.	y
Green	green	nn1_np1@_jj
,	,	y
C.	c	np1
A.	a	zz
,	,	y
&;		null
Polen	polen	np1_nn1
,	,	y
M.	m	nn1
R.	xx_r	np1
2001	2001	mc
The	the	at
health	health	nn1
and	and	cc
health	health	nn1
behaviors	behavior	nn2
of	of	io
people	people	nn
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
Medicine	medicine	nn1
,	,	y
21(4)		fo
,	,	y
298-305	298-305	mcmc
.	.	y
Gutjahr	gutjahr	vv0_nn1_np1@
,	,	y
E.	e	np1
,	,	y
Gmel		np1
,	,	y
G.	g	np1
,	,	y
&;		null
Rehm	rehm	np1_nn1
,	,	y
J.	xx_j	np1
2001	2001	mc
Relation	relation	nn1
between	between	ii
average	average	jj_nn1
alcohol	alcohol	nn1
consumption	consumption	nn1
and	and	cc
disease	disease	nn1
:	:	y
An	a	at1
overview	overview	nn1
.	.	y
European	european	jj
Addiction	addiction	nn1
Research	research	nn1
,	,	y
7(3)	7(3)	fo
,	,	y
117-127		mcmc
.	.	y
Hall	hall	nn1
,	,	y
W.	w	np1
,	,	y
&;		null
Solowij	solowij	np1
,	,	y
N.	xx_n	np1_nnu
1998	1998	mc
Adverse	adverse	jj
effects	effect	nn2
of	of	io
cannabis	cannabis	nn1
.	.	y
Lancet	lancet	np1
,	,	y
352(9140)		fo
,	,	y
1611-1616		mcmc
.	.	y
Henry-Edwards		np1
,	,	y
S.	s	zz
,	,	y
Humeniuk		np1_vv0_nn1
,	,	y
R.	xx_r	np1
,	,	y
Ali	ali	np1
,	,	y
R.	xx_r	np1
,	,	y
Poznyak		np1
,	,	y
V.	xx_v	nnu
,	,	y
&;		null
Monteiro	monteiro	np1
,	,	y
M.	m	nn1
2003	2003	mc
The	the	at
alcohol	alcohol	nn1
,	,	y
smoking	smoke	vvg_jj_nn1
and	and	cc
substance	substance	nn1
involvement	involvement	nn1
screening	screening	nn1_vvg
test	test	nn1
(	(	y
ASSIST	assist	vv0
)	)	y
:	:	y
Guidelines	guideline	nn2
for	for	if
use	use	nn1
in	in	ii
primary	primary	jj_nn1
care	care	nn1
(	(	y
Version	version	nn1
5	5	mc
)	)	y
.	.	y
Geneva	geneva	np1
,	,	y
Switzerland	switzerland	np1
:	:	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
.	.	y
Humeniuk	humeniuk	vv0_nn1_np1@
,	,	y
R.	xx_r	np1
,	,	y
Ali	ali	np1
,	,	y
R.	xx_r	np1
,	,	y
Babor	babor	np1_nn1
,	,	y
T.	t	np1
F.	f	np1
,	,	y
Farrell	farrell	np1
,	,	y
M.	m	nn1
,	,	y
Formigoni	formigoni	np1_nn1
,	,	y
M.	m	nn1
L.	l	zz
,	,	y
Jittiwutikarn		np1_vv0_nn1
,	,	y
J.	xx_j	np1
,	,	y
de	de	np1_fw
Lacerda	lacerda	np1
,	,	y
R.	xx_r	np1
B.	b	np1
,	,	y
Ling	ling	nn1
,	,	y
W.	w	np1
,	,	y
Marsden	marsden	np1_nn1
,	,	y
J.	xx_j	np1
,	,	y
Monteiro	monteiro	np1
,	,	y
M.	m	nn1
,	,	y
Nhiwatiwa		np1
,	,	y
S.	s	zz
,	,	y
Pal	pal	nn1
,	,	y
H.	h	np1
,	,	y
Poznyak		np1
,	,	y
V.	xx_v	nnu
,	,	y
&;		null
Simon	simon	np1
,	,	y
S.	s	zz
2008	2008	mc
Validation	validation	nn1
of	of	io
the	the	at
alcohol	alcohol	nn1
,	,	y
smoking	smoke	vvg_jj_nn1
and	and	cc
substance	substance	nn1
involvement	involvement	nn1
screening	screening	nn1_vvg
test	test	nn1
(	(	y
ASSIST	assist	vv0
)	)	y
.	.	y
Addiction	addiction	nn1
,	,	y
103(6)		fo
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
treatment	treatment	nn1
for	for	if
alcohol	alcohol	nn1
problems	problem	nn2
.	.	y
Washington	washington	np1
,	,	y
DC	dc	np1
:	:	y
National	national	jj
Academy	academy	nn1
Press	press	nn1
.	.	y
Klatsky	klatsky	np1@_jj
,	,	y
A.	a	zz
L.	l	zz
,	,	y
Armstron	armstron	np1_nn1
,	,	y
M.	m	nn1_nnu@
A.	a	zz
,	,	y
&;		null
Freidman	freidman	np1_nn1
,	,	y
G.	g	np1
D.	d	np1
1992	1992	mc
Alcohol	alcohol	nn1
and	and	cc
mortality	mortality	nn1
.	.	y
Annals	annal	nn2
of	of	io
Internal	internal	jj
Medicine	medicine	nn1
,	,	y
117	117	mc
,	,	y
646-654		mcmc
.	.	y
Lange	lange	np1
,	,	y
R.	xx_r	np1
A.	a	zz
,	,	y
&;		null
Hillis	hillis	np1
,	,	y
L.	l	zz
D.	d	np1
2001	2001	mc
Cardiovascular	cardiovascular	jj
complications	complication	nn2
of	of	io
cocaine	cocaine	nn1
use	use	nn1
.	.	y
New	new	np1
England	england	np1
Journal	journal	nn1
of	of	io
Medicine	medicine	nn1
,	,	y
345(5)		fo
,	,	y
351-358		mcmc
.	.	y
Mager	mager	vv0_nn1_np1@
,	,	y
A.	a	zz
2004	2004	mc
White	white	jj
liquor	liquor	nn1
hits	hit	vvz
black	black	jj
livers	liver	nn2
:	:	y
Meanings	meaning	nn2
of	of	io
excessive	excessive	jj
liquor	liquor	nn1
consumption	consumption	nn1
in	in	ii
South	south	np1
Africa	africa	np1
in	in	ii
the	the	at
second	second	md
half	half	nn1
of	of	io
the	the	at
twentieth	twentieth	md
century	century	nnt1
.	.	y
Social	social	jj
Science	science	nn1
&;		null
Medicine	medicine	nn1
,	,	y
59(4)		fo
,	,	y
735-751		mcmc
.	.	y
Magruder-Habib		np1
,	,	y
K.	k	np1
,	,	y
Durand	durand	np1
,	,	y
A.		zz
M.	m	nno@_nn1
,	,	y
&;		null
Frey	frey	np1
,	,	y
K.	k	np1
A.	a	zz
1991	1991	mc
Alcohol	alcohol	nn1
abuse	abuse	nn1
and	and	cc
alcoholism	alcoholism	nn1
in	in	ii
primary	primary	jj_nn1
health	health	nn1
care	care	nn1
settings	setting	nn2
.	.	y
Journal	journal	nn1
of	of	io
Family	family	nn1
Practice	practice	nn1
,	,	y
32(4)		fo
,	,	y
406-413		mcmc
.	.	y
McIntyre	mcintyre	np1
,	,	y
D.	d	np1
,	,	y
Muirhead	muirhead	np1
,	,	y
D.	d	np1
,	,	y
&;		null
Gilson	gilson	np1
,	,	y
L.	l	zz
2002	2002	mc
Geographic	geographic	jj
patterns	pattern	nn2
of	of	io
deprivation	deprivation	nn1
in	in	ii
South	south	np1
Africa	africa	np1
:	:	y
Informing	inform	vvg_nn1
health	health	nn1
equity	equity	nn1
analyses	analysis	nn2_vvz
and	and	cc
public	public	jj_nn1
resource	resource	nn1
allocation	allocation	nn1
strategies	strategy	nn2
.	.	y
Health	health	nn1
Policy	policy	nn1
and	and	cc
Planning	planning	nn1_vvg
,	,	y
17	17	mc
(	(	y
Suppl.	suppl	np1
)	)	y
30-39	30-39	mcmc
.	.	y
McKinstry	mckinstry	np1
,	,	y
J.	xx_j	np1
2005	2005	mc
Using	use	vvg
the	the	at
past	past	jj_nn1
to	to	to
step	step	vvi
forward	forward	rl
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
South	south	np1
Africa	africa	np1
.	.	y
American	american	jj
Journal	journal	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
,	,	y
95(7)		fo
,	,	y
1097-1099		mcmc
.	.	y
Mertens	mertens	np1@_vvz
,	,	y
J.	xx_j	np1
R.	xx_r	np1
,	,	y
Lu	lu	np1_nn1
,	,	y
Y.	y	np1
W.	w	np1
,	,	y
Parthasarathy	parthasarathy	np1_nn1
,	,	y
S.	s	zz
,	,	y
Moore	moore	np1
,	,	y
C.	c	np1_zz1@
,	,	y
&;		null
Weisner	weisner	np1_nn1
,	,	y
C.	c	np1
M.	m	nn1
2003	2003	mc
Medical	medical	jj
and	and	cc
psychiatric	psychiatric	jj
conditions	condition	nn2
of	of	io
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
treatment	treatment	nn1
patients	patient	nn2
in	in	ii
an	a	at1
HMO	hmo	nn1_np1
:	:	y
Comparison	comparison	nn1
with	with	iw
matched	matched	jj@
controls	control	nn2
.	.	y
Archives	archive	nn2
of	of	io
Internal	internal	jj
Medicine	medicine	nn1
,	,	y
163(20)		fo
,	,	y
2511-2517		mcmc
.	.	y
Mertens	mertens	np1@_vvz
,	,	y
J.	xx_j	np1
R.	xx_r	np1
,	,	y
Moos	moos	np1_nn2
,	,	y
R.	xx_r	np1
H.	h	np1
,	,	y
&;		null
Brennan	brennan	np1
,	,	y
P.	xx_p	np1
L.	l	zz
1996	1996	mc
Alcohol	alcohol	nn1
consumption	consumption	nn1
,	,	y
life	life	nn1
context	context	nn1
,	,	y
and	and	cc
coping	cope	vvg_nn1@
predict	predict	vv0
mortality	mortality	nn1
among	among	ii
late-middle-aged	late-middle-aged	jj_nn1
drinkers	drinker	nn2
and	and	cc
former	former	da
drinkers	drinker	nn2
.	.	y
Alcoholism	alcoholism	nn1
:	:	y
Clinical	clinical	jj
and	and	cc
Experimental	experimental	jj
Research	research	nn1
,	,	y
20(2)		fo
,	,	y
313-319		mcmc
.	.	y
Mertens	mertens	np1@_vvz
,	,	y
J.	xx_j	np1
R.	xx_r	np1
,	,	y
Weisner	weisner	np1_nn1
,	,	y
C.	c	np1_zz1@
,	,	y
Ray	ray	np1
,	,	y
G.	g	np1
T.	t	np1
,	,	y
Fireman	fireman	nn1
,	,	y
B.	b	np1
,	,	y
&;		null
Walsh	walsh	np1
,	,	y
K.	k	np1
2005	2005	mc
Hazardous	hazardous	jj
drinkers	drinker	nn2
and	and	cc
drug	drug	nn1
users	user	nn2
in	in	ii
HMO	hmo	np1_nn1
primary	primary	jj_nn1
care	care	nn1
:	:	y
Prevalence	prevalence	np1
,	,	y
medical	medical	jj
conditions	condition	nn2
,	,	y
and	and	cc
costs	cost	nn2_vvz
.	.	y
Journal	journal	nn1
of	of	io
Studies	study	nn2
on	on	ii
Alcohol	alcohol	nn1
,	,	y
29(6)		fo
,	,	y
989-998		mcmc
.	.	y
National	national	jj
Institute	institute	nn1
on	on	ii
Alcohol	alcohol	nn1
Abuse	abuse	nn1
and	and	cc
Alcoholism	alcoholism	nn1
2000	2000	mc
10th	10th	md
special	special	jj
report	report	nn1
to	to	ii
the	the	at
U.S.	us	np1
Congress	congress	nn1
on	on	ii
alcohol	alcohol	nn1
and	and	cc
health	health	nn1
,	,	y
highlights	highlight	vvz_nn2
from	from	ii
current	current	jj
research	research	nn1
,	,	y
June	june	npm1
2000	2000	mc
.	.	y
Washington	washington	np1
:	:	y
Government	government	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
2005	2005	mc
Helping	helping	nn1_vvg
patients	patient	nn2
who	who	pnqs
drink	drink	vv0
too	too	rg
much	much	rr
:	:	y
A	a	at1@_zz1
clinician	clinician	nn1
's	's	ge
guide	guide	nn1
,	,	y
updated	update	vvd_vvn
2005	2005	mc
edition	edition	nn1
.	.	y
Rockville	rockville	np1
,	,	y
MD	md	nna
.	.	y
Newcombe	newcombe	vv0_nn1_np1@
,	,	y
D.	d	np1
A.	a	zz
,	,	y
Humeniuk		np1_vv0_nn1
,	,	y
R.	xx_r	np1
E.	e	np1
,	,	y
&;		null
Ali	ali	np1
,	,	y
R.	xx_r	np1
2005	2005	mc
Validation	validation	nn1
of	of	io
the	the	at
World	world	nn1
Health	health	nn1
Organization	organization	nn1
alcohol	alcohol	nn1
,	,	y
smoking	smoke	vvg_jj_nn1
and	and	cc
substance	substance	nn1
involvement	involvement	nn1
screening	screening	nn1_vvg
test	test	nn1
(	(	y
ASSIST	assist	vv0
)	)	y
:	:	y
Report	report	nn1
of	of	io
results	result	nn2
from	from	ii
the	the	at
Australian	australian	jj
site	site	nn1
.	.	y
Drug	drug	nn1
and	and	cc
Alcohol	alcohol	nn1
Review	review	nn1
,	,	y
24(3)	24(3)	fo
,	,	y
217-226		mcmc
Raab	raab	np1_nn1@
,	,	y
G.	g	np1_nnu@
M.	m	nn1_nno@
1992	1992	mc
Alcohol	alcohol	nn1
and	and	cc
non-malignant	non-malignant	jj
gastrointestinal	gastrointestinal	jj
disease	disease	nn1
.	.	y
In	in	ii
J.	xx_j	np1
C.	c	np1
Duffy	duffy	np1
(	(	y
Ed	ed	np1
.	.	y
)	)	y
,	,	y
Alcohol	alcohol	nn1
and	and	cc
illness	illness	nn1
:	:	y
The	the	at
epidemiological	epidemiological	jj
viewpoint	viewpoint	nn1
(	(	y
pp.	pp	nnu2
136-144		mcmc
)	)	y
.	.	y
Edinburgh	edinburgh	np1
,	,	y
Scotland	scotland	np1
:	:	y
Edinburgh	edinburgh	np1
University	university	nn1
Press	press	nn1
.	.	y
Reid	reid	np1
,	,	y
M.	m	nn1
C.	c	np1_zz1@
,	,	y
Fiellin		np1
,	,	y
D.	d	np1
A.	a	zz
,	,	y
&;		null
O'Connor	o'connor	np1
,	,	y
P.	xx_p	np1
G.	g	np1
1999	1999	mc
Hazardous	hazardous	jj
and	and	cc
harmful	harmful	jj
alcohol	alcohol	nn1
consumption	consumption	nn1
in	in	ii
primary	primary	jj_nn1
care	care	nn1
.	.	y
Archives	archive	nn2
of	of	io
Internal	internal	jj
Medicine	medicine	nn1
,	,	y
159(15)		fo
,	,	y
1681-1689		mcmc
.	.	y
Rodgers	rodgers	np1
,	,	y
A.	a	zz
2002	2002	mc
Quantifying	quantifying	np1_vvg_jj@
selected	select	vvd@_jj
major	major	jj
risks	risk	nn2
to	to	ii
health	health	nn1
.	.	y
In	in	ii
C.	c	np1
Murray	murray	np1
&;		null
A.	a	zz
Lopez	lopez	np1
(	(	y
Eds	ed	nn2
.	.	y
)	)	y
,	,	y
The	the	at
World	world	nn1
health	health	nn1
report	report	nn1
2002	2002	mc
:	:	y
Reducing	reduce	vvg_jj@
risks	risk	nn2
,	,	y
promoting	promote	vvg
healthy	healthy	jj
life	life	nn1
.	.	y
Geneva	geneva	np1
,	,	y
Switzerland	switzerland	np1
:	:	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
.	.	y
Rothman	rothman	nn1_np1@
,	,	y
K.	k	np1
J.	xx_j	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
,	,	y
1(1)	1(1)	fo
,	,	y
43-46	43-46	mcmc
.	.	y
Rubin	rubin	nn1_np1@
,	,	y
R.	xx_r	np1
B.	b	np1
,	,	y
&;		null
Neugarten	neugarten	np1_vv0
,	,	y
J.	xx_j	np1
1992	1992	mc
Medical	medical	jj
complications	complication	nn2
of	of	io
cocaine	cocaine	nn1
:	:	y
Changes	change	nn2
in	in	ii
pattern	pattern	nn1
of	of	io
use	use	nn1
and	and	cc
spectrum	spectrum	nn1
of	of	io
complications	complication	nn2
.	.	y
Journal	journal	nn1
of	of	io
Toxicology	toxicology	nn1_np1
.	.	y
Clinical	clinical	jj
Toxicology	toxicology	nn1_np1
,	,	y
30(1)	30(1)	fo
,	,	y
1-12	1-12	mcmc
.	.	y
Sikkink	sikkink	vv0_nn1_np1@
,	,	y
J.	xx_j	np1
,	,	y
&;		null
Fleming	fleming	np1
,	,	y
M.	m	nnu@_nn1
F.	f	ra@_np1
1992	1992	mc
Adverse	adverse	jj
health	health	nn1
effects	effect	nn2
and	and	cc
medical	medical	jj
complications	complication	nn2
of	of	io
alcohol	alcohol	nn1
,	,	y
nicotine	nicotine	nn1
,	,	y
and	and	cc
drug	drug	nn1
abuse	abuse	nn1
.	.	y
In	in	ii
M.	m	nn1_nnu@
F.	f	np1_ra@
Fleming	fleming	np1
,	,	y
&;		null
K.	k	np1
L.	l	zz
Barry	barry	np1
(	(	y
Eds	ed	nn2
.	.	y
)	)	y
,	,	y
Addictive	addictive	jj
disorders	disorder	nn2
:	:	y
A	a	zz1_at1@
practical	practical	jj
guide	guide	nn1
to	to	ii
treatment	treatment	nn1
(	(	y
pp.	pp	nnu2
145-168		mcmc
)	)	y
.	.	y
St.	st	np1
Louis	louis	np1
:	:	y
Mosby-Year	mosby-year	jj
Book	book	nn1
Primary	primary	nn1_jj
Care	care	nn1_vv0
Series	series	nn
.	.	y
Stein	stein	nn1_np1@
,	,	y
M.	m	nn1
D.	d	np1
1999	1999	mc
Medical	medical	jj
consequences	consequence	nn2
of	of	io
substance	substance	nn1
abuse	abuse	nn1
.	.	y
Psychiatric	psychiatric	jj
clinics	clinic	nn2
of	of	io
North	north	nd1
America	america	np1
,	,	y
22(2)		fo
,	,	y
351-370		mcmc
.	.	y
The	the	at
World	world	nn1
Medical	medical	jj
Association	association	nn1
2005	2005	mc
The	the	at
Worm	worm	nn1
Medical	medical	jj
Association	association	nn1
statement	statement	nn1
on	on	ii
reducing	reduce	vvg
the	the	at
global	global	jj
impact	impact	nn1
of	of	io
alcohol	alcohol	nn1
on	on	ii
health	health	nn1
and	and	cc
society	society	nn1
.	.	y
Preamble	preamble	nn1
.	.	y
Santiago	santiago	np1
,	,	y
Chile	chile	np1
:	:	y
The	the	at
World	world	nn1
Medical	medical	jj
Association	association	nn1
.	.	y
Ward	ward	np1_nn1
,	,	y
C.	c	np1
L.	l	zz
,	,	y
Mertens	mertens	np1_vvz
,	,	y
J.	xx_j	np1
R.	xx_r	np1
,	,	y
Flisher	flisher	np1@_jjr
,	,	y
A.	a	zz
J.	xx_j	np1
,	,	y
Bresick		np1_jj
,	,	y
G.	g	np1
F.	f	np1_ra@
,	,	y
Sterling	sterling	nn1
,	,	y
S.	s	zz
,	,	y
Distiller	distiller	nn1
,	,	y
G.	g	np1
B.	b	np1
,	,	y
&;		null
Weisner	weisner	np1_nn1
,	,	y
C.	c	np1
M.	m	nn1
2005	2005	mc
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
health	health	nn1
care	care	nn1
service	service	nn1
users	user	nn2
.	.	y
South	south	np1
African	african	jj
Psychiatry	psychiatry	nn1_np1
Review	review	nn1_np1@
,	,	y
8	8	mc
,	,	y
160-165	160-165	mcmc
.	.	y
Ward	ward	np1_nn1
,	,	y
C.	c	np1
L.	l	zz
,	,	y
Mertens	mertens	np1_vvz
,	,	y
J.	xx_j	np1
R.	xx_r	np1
,	,	y
Flisher	flisher	np1@_jjr
,	,	y
A.	a	zz
J.	xx_j	np1
,	,	y
Bresick		np1_jj
,	,	y
G.	g	np1
F.	f	np1_ra@
,	,	y
Sterling	sterling	nn1
,	,	y
S.	s	zz
,	,	y
Little	little	rr_jj
,	,	y
F.	f	np1_ra@
,	,	y
&;		null
Weisner	weisner	np1_nn1
,	,	y
C.	c	np1_zz1@
2008	2008	mc
Substance	substance	nn1
use	use	nn1_vv0
in	in	ii
South	south	np1
African	african	jj
primary	primary	jj_nn1
care	care	nn1
clinics	clinic	nn2
.	.	y
Substance	substance	nn1
Use	use	nn1_vv0
&;		null
Misuse	misuse	nn1
.	.	y
WHO	who	np1_pnqs@
ASSIST	assist	vv0
Working	working	jj
Group	group	nn1
2002	2002	mc
The	the	at
alcohol	alcohol	nn1
,	,	y
smoking	smoke	vvg_jj_nn1
and	and	cc
substance	substance	nn1
involvement	involvement	nn1
screening	screening	nn1_vvg
test	test	nn1
(	(	y
ASSIST	assist	vv0
)	)	y
:	:	y
Development	development	nn1
,	,	y
reliability	reliability	nn1
and	and	cc
feasibility	feasibility	nn1
.	.	y
Addiction	addiction	nn1
,	,	y
97(9)		fo
,	,	y
1183-1194		mcmc
.	.	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
2005	2005	mc
Country	country	nn1
profile	profile	nn1
.	.	y
South	south	np1
Africa	africa	np1
tuberculosis	tuberculosis	nn1
incidence/prevalence	incidence/prevalence	nn1
,	,	y
vol.	volume	nnu
2006	2006	mc
.	.	y
Geneva	geneva	np1
,	,	y
Switzerland	switzerland	np1
:	:	y
World	world	nn1
Health	health	nn1
Organization	organization	nn1
.	.	y
By	by	ii
Jennifer	jennifer	np1
R.	xx_r	np1
Mertens	mertens	np1_vvz
;	;	y
Alan	alan	np1
J.	xx_j	np1
Flisher	flisher	np1@_nn1@
;	;	y
Catherine	catherine	np1
L.	l	zz
Ward	ward	np1
;	;	y
Graham	graham	np1
F.	f	np1
Bresick		np1
;	;	y
Stacy	stacy	np1
A.	a	zz
Sterling	sterling	nn1
and	and	cc
Constance	constance	np1
M.	m	nn1
Weisner	weisner	np1_nn1
Jennifer	jennifer	np1
R.	xx_r	np1
Mertens	mertens	np1
,	,	y
Ph.D.	ph.d	nna
,	,	y
is	be	vbz
a	a	at1
Scientist	scientist	nn1
at	at	ii
the	the	at
Division	division	nn1
of	of	io
Research	research	nn1
,	,	y
Kaiser	kaiser	nnb
Permanente	permanente	np1
Medical	medical	jj
Care	care	nn1
Program	program	nn1
in	in	ii
Oakland	oakland	np1
,	,	y
California	california	np1
.	.	y
Her	her	appge
research	research	nn1
interests	interest	nn2
include	include	vv0
the	the	at
long-term	long-term	jj
course	course	nn1
of	of	io
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
treatment	treatment	nn1
,	,	y
alcohol	alcohol	nn1
and	and	cc
drug	drug	nn1
epidemiology	epidemiology	nn1
,	,	y
and	and	cc
early	early	jj
interventions	intervention	nn2
in	in	ii
medical	medical	jj
settings	setting	nn2
.	.	y
Alan	alan	np1
J.	xx_j	np1
Flisher	flisher	np1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
the	the	at
Sue	sue	np1
Streungmann		np1
Professor	professor	nn1
of	of	io
Child	child	nn1
and	and	cc
Adolescent	adolescent	jj_nn1
Psychiatry	psychiatry	nn1_np1
and	and	cc
Mental	mental	jj
Health	health	nn1
at	at	ii
the	the	at
University	university	nn1
of	of	io
Cape	cape	np1
Town	town	np1
(	(	y
UCT	uct	np1
)	)	y
,	,	y
Head	head	nn1
of	of	io
the	the	at
Division	division	nn1
of	of	io
Child	child	nn1
and	and	cc
Adolescent	adolescent	jj_nn1
Psychiatry	psychiatry	nn1
at	at	ii
UCT	uct	np1_nn1
,	,	y
Director	director	nn1
of	of	io
the	the	at
Adolescent	adolescent	jj_nn1
Health	health	nn1
Research	research	nn1
Institute	institute	nn1
at	at	ii
UCT	uct	np1_nn1
,	,	y
and	and	cc
Professor	professor	nn1
II	ii	mc
at	at	ii
the	the	at
Research	research	nn1
Centre	centre	nn1
for	for	if
Health	health	nn1
Promotion	promotion	nn1
at	at	ii
the	the	at
University	university	nn1
of	of	io
Bergen	bergen	np1
,	,	y
Norway	norway	np1
.	.	y
Catherine	catherine	np1
L.	l	zz
Ward	ward	np1
,	,	y
Ph.D.	ph.d	nna
,	,	y
is	be	vbz
a	a	at1
Senior	senior	jj
Lecturer	lecturer	nn1
in	in	ii
the	the	at
Department	department	nn1
of	of	io
Psychology	psychology	nn1
at	at	ii
the	the	at
University	university	nn1
of	of	io
Cape	cape	np1
Town	town	np1
,	,	y
South	south	np1
Africa	africa	np1
.	.	y
She	she	pphs1
is	be	vbz
a	a	at1
clinical-community	clinical-community	jj_nn1
psychologist	psychologist	nn1
whose	whose	ddqge
research	research	nn1
interests	interest	nn2
include	include	vv0
violence	violence	nn1
exposure	exposure	nn1
and	and	cc
its	its	z'
consequences	consequence	nn2
for	for	if
development	development	nn1
and	and	cc
well-being	well-being	nn1
,	,	y
including	including	ii_vvg@
substance	substance	nn1
misuse	misuse	nn1
.	.	y
Graham	graham	np1
F.	f	np1
Bresick		np1
,	,	y
MB.Ch.B		np1
,	,	y
DCH	dch	np1
,	,	y
MPH	mph	nnu
,	,	y
is	be	vbz
a	a	at1
senior	senior	jj
lecturer	lecturer	nn1
in	in	ii
the	the	at
School	school	nn1
of	of	io
Public	public	jj_nn1
Health	health	nn1
&;		null
Family	family	nn1
Medicine	medicine	nn1
,	,	y
University	university	nn1
of	of	io
Cape	cape	np1
Town	town	np1
,	,	y
where	where	cs_rrq
he	he	pphs1
teaches	teach	vvz
family	family	nn1
medicine	medicine	nn1
and	and	cc
motivational	motivational	jj
interviewing	interviewing	nn1@_vvg
to	to	ii
undergraduate	undergraduate	nn1
and	and	cc
postgraduate	postgraduate	nn1
medical	medical	jj
students	student	nn2
,	,	y
convenes	convene	vvz
final	final	jj
year	year	nnt1
MB.Ch.B		np1
family	family	nn1
medicine	medicine	nn1
clerkship	clerkship	nn1
in	in	ii
district-based	district-based	jj_nn1
health	health	nn1
services	service	nn2
,	,	y
and	and	cc
conducts	conduct	vvz_nn2
primary	primary	jj_nn1
care	care	nn1
research	research	nn1
.	.	y
Stacy	stacy	nn1_np1@
Sterling	sterling	nn1
,	,	y
MSW	msw	np1
,	,	y
MPH	mph	nnu
,	,	y
is	be	vbz
a	a	at1
Senior	senior	jj
Research	research	nn1
Project	project	nn1
Manager	manager	nn1
at	at	ii
the	the	at
Division	division	nn1
of	of	io
Research	research	nn1
,	,	y
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
Her	her	appge
research	research	nn1
interests	interest	nn2
include	include	vv0
developing	developing	jj_vvg
health	health	nn1
policies	policy	nn2
to	to	to
improve	improve	vvi
treatment	treatment	nn1
for	for	if
adolescents	adolescent	nn2
and	and	cc
women	woman	nn2
,	,	y
and	and	cc
the	the	at
integration	integration	nn1
of	of	io
research	research	nn1
findings	finding	nn2
into	into	ii
clinical	clinical	jj
practice	practice	nn1
.	.	y
Constance	constance	np1
M.	m	nn1
Weisner	weisner	nn1_np1
,	,	y
DrPH	drph	np1
,	,	y
MSW	msw	np1
is	be	vbz
an	a	at1
Investigator	investigator	nn1
at	at	ii
the	the	at
Division	division	nn1
of	of	io
Research	research	nn1
,	,	y
Kaiser	kaiser	nnb
Permanente	permanente	np1
Medical	medical	jj
Care	care	nn1
Program	program	nn1
in	in	ii
Oakland	oakland	np1
,	,	y
California	california	np1
and	and	cc
a	a	at1
Professor	professor	nn1
in	in	ii
the	the	at
Department	department	nn1
of	of	io
Psychiatry	psychiatry	np1_nn1
,	,	y
University	university	nn1
of	of	io
California	california	np1
,	,	y
San	san	np1
Francisco	francisco	np1
.	.	y
Her	her	appge
research	research	nn1
interests	interest	nn2
include	include	vv0
outcomes	outcome	nn2
and	and	cc
costs	cost	nn2
of	of	io
chemical	chemical	jj_nn1
dependency	dependency	nn1
treatment	treatment	nn1
interventions	intervention	nn2
.	.	y
